CORONA Main Coronavirus thread

Heliobas Disciple

TB Fanatic
(fair use applies)

US Vaccination Rates Collapse As Omicron Subsides
by Tyler Durden
Thursday, Feb 24, 2022 - 11:20 PM

As cases of the already-more-mild Omicron strain of Covid-19 subside, vaccination rates in the United States are collapsing, according to AP, which reports that the vaccination drive in the US is 'grinding to a halt,' and 'demand has all but collapsed' - particularly in rural areas.

At present, the average number of Americans getting their first dose is down to around 90,000 per day - the lowest point since the first few days of the vaccination campaign in December 2020 - while the outlook for any sort of substantial increase has largely evaporated.

AP of course acts like this is a national tragedy led by toothless rednecks in 'deeply conservative' parts of the country, suggesting a 'losing battle to get people vaccinated' in rural Alabama - but of course the reality goes unmentioned... that the vaccine largely evades Omicron - which is far less deadly than previous strains, and is only marginally effective in keeping medically at-risk people from dying.



Even the Washington Post noted on Wednesday: "Coronavirus vaccine protection was much weaker against omicron, data shows."

While coronavirus shots still provided protection during the omicron wave, the shield of coverage they offered was weaker than during other surges, according to new data from the Centers for Disease Control and Prevention. The change resulted in much higher rates of infection, hospitalization and death for fully vaccinated adults and even for people who had received boosters. -WaPo

Meanwhile, government vaccination incentive programs that gave away cash, beer, sports tickets and other prizes have also disappeared - while governnment and employer vaccine mandates have suffered blows in court.

"People are just over it. They’re tired of it," said Judy Smith, administrator for a 12-county public health district in northwestern Alabama.

The bottoming-out of demand for the first round of vaccinations is especially evident in conservative areas around the country.

On most days in Idaho, the number of people statewide getting their first shot rarely surpasses 500.

In Wyoming, a total of about 280 people statewide got their first shot in the past week, and the waiting area at the Cheyenne-Laramie County Health Department stood empty Tuesday morning. The head of the department fondly recalled just a few months ago, when the lobby was bustling on Friday afternoons after school with children getting their doses. But they aren’t showing up anymore either. -AP

"People heard more stories about, well, the omicron’s not that bad," said Executive Director Kathy Emmons. "I think a lot of people just kind of rolled the dice and decided, ‘Well, if it’s not that bad, I’m just going to kind of wait it out and see what happens.’"
.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

German Health Insurer Reveals 'Alarming' Underreporting Of Vaccine Side-Effects
by Tyler Durden
Thursday, Feb 24, 2022 - 07:45 AM

A large German health insurance provider revealed on Wednesday that Covid-19 vaccine side-effects are vastly underreported, according to Welt.

After analyzing data from over 10 million individuals, BKK ProVita board member Andreas Schöfbeck, over a 7.5 month period beginning in early 2021, 216,695 policyholders out of 10.9 million were treated for vaccine side-effects. This compares to 244,576 reports out of 61.4 million reported by the Paul Ehrlich Institute - a German federal agency.
Germany has a population of around 83 million people.

Schöfbeck called the data an "alarm signal," adding "The numbers determined are significant and urgently need to be checked for plausibility."

"The data available to our company gives us reason to believe that there is a very considerable under-recording of suspected cases of vaccination side-effects after they received the [COVID-19] vaccine."

“If these figures are applied to the year as a whole and to” the entire population of Germany, Schöfbeck estimated, then “probably 2.5-3 million people in Germany been under medical treatment because of vaccination side effects after [COVID-19] vaccination.

As Jack Phillips of The Epoch Times notes:

Schöfbeck concluded that based on their data, “there is a significant underreporting of vaccination side-effects” in Germany.
Another letter that was sent out by BKK (pdf) suggested that vaccination side effects reported across Germany are at least 10 times more common than what was reported by the Paul-Ehrlich Institute, reported the Nordkurier newspaper on Wednesday.
Schöfbeck’s letters were also sent to Germany’s Standing Vaccination Commission and the German Medical Association.
The letters did not elaborate on the severity of the side effects, nor did they provide a breakdown of the symptoms, or which vaccines caused the side effects. Germany’s drug regulator has approved COVID-19 vaccines manufactured by Pfizer, AstraZeneca, Johnson & Johnson, NovaVax, and Moderna.
Federal health officials in the United States and Germany have stressed that COVID-19 vaccines’ benefits outweigh the potential risks.
And the Paul Ehrlich Institute, the German federal health agency that regulates vaccines and medicines, asserts on its website that COVID-19 vaccine side effects are very rare. They list myocarditis, the inflammation of the heart muscle; and pericarditis, the inflammation of the pericardium, as rare side effects associated with COVID-19 vaccines.
* * *


This German Insurance company called out the public data as too low & mentioned ethics…this provides cover for others in the insurance industry to follow suit & they will. The tsunami of news flow will be uncontrollable for the propagandists.
2/23/2022 the day the levee broke! pic.twitter.com/EUf7OFqsea
— Ed Free Thinker & Oracle (@DowdEdward) February 23, 2022
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Scientific Fraud and the CDC
These are the people entrusted with the truth

WND EXCLUSIVE

'Scientific fraud': Drs. Robert Malone, Ryan Cole react to CDC hiding data
'These are the people that are entrusted to tell us the truth'



  • Dr. Cole and I sat down with Art Moore in Washington State on Monday to talk about the CDC covering up data, scientific fraud and what comes next. The video is linked above. But for those who prefer to read, the full transcript of the conversation is below.
  • Note: the above link is not being allowed to be forwarded by T-mobile and probably other cell phone services. Evidently speaking about censorship and scientific fraud is considered too dangerous by our government.
The conversation begins with:

Mr. Art Moore:
I'm Art Moore in Gig Harbor, Washington, here with Dr. Robert Malone, Dr. Ryan Cole. And we're here with parents and activists and lawmakers who are really concerned about this safety issue regarding the COVID vaccines. And we've talked about the CDC data that's on the VAERS database and the fact that it is in spite of accusations that it's not reliable.
It is giving us some alarming safety signals. But now we come to a blockbuster story. The New York Times has interviewed CDC officials who admit that they have data that goes beyond this VAERS data. They have granular data that is indicating how many people have been hospitalized deaths. Other data regarding the impact of these vaccines that they admit they've been hiding and hiding because they're concerned about vaccine hesitancy.
Dr. Cole, what's your reaction to that?
Dr. Ryan Cole
Well, as an ethical physician who took oaths to the human race, this is incredibly disturbing. These are the people that are entrusted to share with us the truth, to know that they're withholding safety data signals all in the name of trying to prevent a hesitancy over something experimental that's being used not only on adults, but trying to push this forward on children with no long term safety record.
We can't advance the clock and know what the long term outcomes are. We now to know that they know that there are problems and they're withholding it from the American people, that is scientific fraud.
Dr. Robert Malone
I completely concur. So I'm just going to read the title and a couple of clips from this blockbuster New York Times piece. And by the way, what I find fascinating is The New York Times is trying to normalize what has been going on at the CDC. They're trying to make it sound like it's acceptable practice. And I strongly concur with Ryan.
This meets the criteria of scientific fraud. Withholding data is scientific fraud. So reading from the title, “The CDC isn't publishing large portions of the COVID data it collects”. New York Times February 21st 2022 just an amazing title. Read that again. “CDC is not publishing large portions of the COVID data it collects.” Then there's a quote from Samuel Scarpino, managing director of the Pathogen Surveillance at the Rockefeller Foundation's Pandemic Prevention Institute. This is somebody who is deeply in the non-governmental sector, speaking on behalf basically of the scientists at the CDC that have failed to disclose this up till now. Here's what he says. Direct quote, "The CDC is a political organization as much as it is a public health organization." I mean, that is totally inconsistent with their charter. He's speaking the truth of the situation, and that's where we're at, the CDC.
He is saying the the CDC is overtly functioning as a political arm of the executive branch as opposed to serving its mandate from Congress. To protect the health and collect the information. In this, as the Centers for Disease Control and Surveillance that is their mission. This guy, Samuel Scarpino, goes on to say, “The steps that it takes to get something like this released are often well outside of the control of many of the scientists who work at the CDC”. Now think that quote through.
Basically a non-governmental spokesperson for the official public health scientific community is throwing Rochelle Walensky, the CDC director, under the bus. What he is saying, if you read think through his words is that the governmental leadership of the CDC has stifled CDC scientists and preventing them from disclosing key information to the public about the risks of the vaccine.
That is stunning.
Art Moore
Dr. Alan, you're well connected. I imagine, you know, many of these scientists, these scientists who are working with the CDC or advise or consult the CDC tell us just from your your experience and your standpoint what this really means Okay.
Dr. Robert Malone
I'm going to speculate because that's what you're asking me to do is kind of give you a sense of what I infer. I mean, right now, nobody's talking to me from inside the government for some reason -except my buddies at the DOD. And even that's a little limited. The CDC staff is a bureaucracy; the physicians and medical scientists sit underneath a political operation.
And for them, you know, this is their paycheck. They are focused on security. Otherwise they wouldn't work for the government at 80% of market rate. They often find themselves in positions where they're not able to really say what they're seeing and what they're experiencing. They're often very frustrated, in my experience, by having to operate underneath this political leadership organization.
And what we've got here is that they're not having the courage, unlike what folks like Ryan and I are doing. We're sticking our careers online. They haven't had the courage to come out and say, “No. This is not right.”
What's going on? So it appears that what they're doing is using a surrogate at the Rockefeller Foundation, an NGO, non non-governmental organization, to speak what they are observing and what they don't have the courage to speak about.
It's time, in my opinion, for the scientists and physicians of the CDC to come clean. It's way past time. But that's what seems to be happening is they have been undercover, observing these things and haven't had the courage to speak out about it. And as the narrative is crumbling, this a bunch of them apparently have gone to the press anonymously, because there's nobody cited on record here.
Multiple scientists are being quoted as sources by the New York Times, but they're all on background. You know what that means? None of them are having the courage to stick their necks out. And they're using a surrogate at the Rockefeller Foundation to to be their spokesperson.
And they got a problem because now they're work, their records, their careers are on the line because it's coming out that what we have is suppression of key public health information for political purpose and they may well have to confront legal consequences at some point in time.
Art Moore
I think I've been listening to you health care scientists over the last couple of days talk about what you're seeing. And so Dr. Cole in your lab and Dr. Malone, you have a big picture view of really horrific signs that there are many people who not only are being severely injured in these vaccines, but dying. And so I wonder, Dr. Cole, just from the standpoint of a physician, you went into this profession because you wanted to help people, and it just seemed that something horrible a scenario is is emerging that that could be beyond comprehension.
What's your sense of what's happening now?
Dr. Ryan Cole
Thank you. And that is the moral and ethical responsibility in all of this. I went into medicine to be a healer, to take care of people. And when I started seeing these signals early on, I knew right away I have one thing and one thing only to do. And that's to tell the truth, whether it's convenient or inconvenient, you have to follow the truth where it goes.
So these players within the CDC, within government agencies, if they see that signal, instead of protecting their career or being worried about what's going to happen to me if I say something, what about the human being that's going to be harmed and damaged by you not saying something? So we as physicians and scientists have one responsibility only, and that's the health and wellness of humanity, no matter the inconvenient cost of telling that truth.
So in a scenario like this, yes, in the lab I started seeing the clotting damage. Yes. I started seeing upticks in autoimmune disease. Yes, I started seeing an uptick in cancers. Did I sound the alarm? You bet I did. And what did I hear from most of my colleagues? Crickets.
Dr. Robert Malone
I'd like to amplify on that. We both come from a background of pathology. I taught pathology at the medical school level for well over a decade, and the historic role of pathologists in the medical profession is basically quality control. We're the final arbiters of truth, and it may be one of the reasons why we've been comfortable speaking out is because that is the nature of our discipline.
That is the historic nature of the role of pathology in medicine is to be the final arbiters of truth. That's what we do. That's what pathologists are about.
Dr. Ryan Cole
Yeah, we don't cause the disease. We're the reporters at the scene of the crash. And when we see the crash, we report on the crash. And very often in medicine, the first person to observe there's a difference in the pattern. And the signal here is the pathologist saying, I'm seeing something new. And then you sound the alarm and you get other colleagues to look at that same signal.
Are they seeing that signal as well?
Art Moore
"Yeah. So when I think back, what I remember is the rebuttal is, “well, you know, we don't have the studies." This is anecdotal.” bBut what you're saying is there's a process. You begin with anecdotal and then you move towards studies.
Dr. Robert Malone
And I wouldn't even say anecdotal, anecdotal as a pejorative.
Dr. Ryan Cole
I would say it's the early signal.
Dr. Robert Malone
Bingo. And when you hear about signal detection.
Dr. Ryan Cole
And worse, we detect that signal and then the signal is starting to amplify because now when we go to conferences and we talk to say, I talked to a surgical oncologist surgeon last night, he's saying he has a young gastric cancer patient, who is a 28 year old, an esophageal cancer who is 31 year old. A radiologist called me yesterday from a multi-center unit, with another 31 year old person dead - within a couple of weeks of their shots. And so when you see these unusual signals and then it gets amplified every time you get another colleague saying thank you for speaking up. “I'm seeing the same signal.” “I'm seeing the same signal.” Now you have an overwhelming amount of evidence that you can call and draw on scientifically.
Dr. Robert Malone
What happens a lot of times is the problem is pattern recognition.
Dr. Ryan Cole
Yes.
Dr. Robert Malone
And pattern recognition is really tough when you're at the tip of the spear because you have no preceding metaphor. And once somebody like Ryan speaks out and saying, says, things like, I've seen signs of these viral diseases cropping up. It's sounds and looks like immunosuppression. I'm seeing signs of unusual cancers cropping up that fits with the immunosuppression” then we're starting to build a pattern.
Okay. And then we say to our colleagues, we're observing this pattern. Are you seeing it also? And when that starts coming back, from people like oncologists and surgeons, then, then then we're starting to say this is looking a little alarming. And it's time to really dig in. What happens that I've seen is once those those ideas, that initial pattern recognition is gone out there, then other people are often able to perceive things that before they might have noticed subconsciously, but they not might not have been aware of.
And that's how medicine progresses.
Dr. Ryan Cole
Now, they may have had a subconscious blind spot, but when you realize that that pattern is clicking upward, they open their eyes and say, I am seeing that. And then the frustration is knowing that we have large data gather gathering agencies for the which we pay with our tax dollars, who say nothing. I pay, we all pay. And then public information coming out saying, oh, we've been seeing those patterns, but we feel like you don't need the whole truth because we need to hide those things.
Dr. Robert Malone
This has been what's gone on all the way through. With Tony Fauci talking about, “well, I told them that you would be reach herd immunity at 70% vaccination because “I thought that's what they could handle and then oh it's 80%”. If you run the calculations, even with Delta it was 140% vaccine coverage to get to herd immunity.
In other words you can't achieve herd immunity when you run the calculations. This is what what we've seen. And we saw this lying really early on - as “the noble lie.” That's what we've been dealing with all the way through and this is just the latest embodiment of the government feeling like the way they need to manage us is with the noble lie of spoon feeding us what they think we can accept, not giving us truth.
Art Moore
The truth is that because they went all in on the vaccines, as if there's no other way to treat this. And it's just easy. One, fix the vaccines. Is that why they're defending? And also, you know, why they're not why they're suppressing the trigger?
Dr. Robert Malone
This gets into the the dangerous territory of thinking that we can get inside of Rochelle's and Tony's head.
Dr. Ryan Cole
It's always hard to answer somebody else's “why?” I can observe data and report data, and my job in medicine is always to follow that data, whether convenient or not, the data tells the truth. If you have the full data, so when full data is being withheld, then the data becomes a partial lie.
To Dr. Malone's point saying, “well, you're not prepared for the truth or we know better.” This is paternalistic and paternalistic. “You're just little children” is really an improper way to treat patients. These agencies are saying “we let you know what truth you're allowed to have or not.” And then you get policymakers, you get governors, you get school boards, saying, well, our policy will be this based on this.
Dr. Robert Malone
You get medical licensing boards.
Dr. Ryan Cole
Coming after people like you and I.
Dr. Robert Malone
Who (medical licensing boards) are often appointed by politicos coming after us, trying to take our license because we've been speaking truth. Because as pathologists, we are trained folk who are able to pick out signal from noise. And we've done it earlier and we haven't been constrained in speaking the truth that we see. The problem is then a lot of the other docs that aren't trained in this kind of signal detection world and only hear the messaging from the government.
Pathologists apply information in science to medicine daily. We're the folks that have to give that truth to them (other doctors). So they know how to manage things clinically. But what's happened is that everybody has assumed that the CDC and the NIH are speaking truth, and as a consequence, they felt justified in attacking us for observing these signals giving these warnings.
And we've had to bear the brunt. And as opposed to our esteemed colleagues inside the government at the CDC, who have failed to disclose what they're observing, we've been the ones at the tip of the spear, taking it from the press, from our licensing boards. And now we find out that, in fact, we're being validated that what we have observed is been hidden from the regular the general community.
And that's the the key point that it bothers me here is that the CDC has a responsibility to communicate accurate information. It represents that it's doing so, and it's communicating both to the general public and to the medical community. And they are now admitting through this New York Times article, multiple sources, that they've been lying to the medical community and that is scientific fraud.
That is the definition, withholding data, scientific data, medical data - that is fraud.
 

Heliobas Disciple

TB Fanatic
CONTINUED


Art Moore

So it sounds essentially like what the government is saying to us non-scientists is you can't handle the truth. Correct?
Dr. Robert Malone
Precisely. It couldn't be any more overt.
Dr. Ryan Cole
And with an article like this coming out, coming out now, we should invite our colleagues who aren’t seeing what they've been told to stand up and say it. They should wake up.
Dr. Robert Malone
They must.
Dr. Ryan Cole
Say it. It is an ethical responsibility to humanity to do so.
Art Moore
And you've been doing that for some time, trying to to wake up and encourage your colleagues from all across this nation.
Dr. Robert Malone
In the world.
Art Moore
And we've heard numbers like there are maybe 500 physicians in America who are awake and nobody can know for sure, but that's a handful or I just a small portion of the physicians here. Tell me, though.
Dr. Robert Malone
I think that was a Pierre Kory quote, and that was four months ago. Okay. But the numbers have been building.
Art Moore
Yeah. What are you seeing?
Dr. Robert Malone
I'm getting calls all the time. You're getting calls. People are coming out of the woodwork. They're hearing this messaging. It is not about us. We are really adamant this is not about us. It's about you and the community and our fellow physicians. But remember, that we're not just two. We represent an organization, the global COVID Summit Group that is over 17,000 physicians and medical scientists from all over the world.
We have all been speaking. But the problem is that there's a concerted effort to censor us and prevent us from speaking. You know, I've been de-platformed on LinkedIn and Twitter. There's all the blowback over the Joe Rogan podcast, a concerted effort in mainstream media. We're so grateful for the at least the conservative media has been willing to talk to us.
But on there has been a concerted effort to keep key information from physicians, scientists and the general public. And now it's out in the open.
Art Moore
And it really begins to make a lot more sense when you look at this New York Times article and just the admission of the direct connection between information and worrying that people will get the vaccine, that seems pretty simple. Yeah. Now, this is going to be a huge issue that I know you two will be talking about in the days to come.
But if we could just briefly move to another issue so back in December, Dr. Malone, you were talking about the Omicron variant. That this wave will have a silver lining. That Omicron itself could act kind of like a natural vaccine. And now just in the last few days, we hear Bill Gates is on video saying, sadly, it seems that Omicron is acting like a natural vaccine.
Dr. Robert Malone
Bill Gates has bragged about how much money he's made off of this outbreak. He made strategic investments based on his situational awareness and somehow had foreshadowing that something like this was coming and placed his financial bets. He's made a lot of money on this.
So there's this odd use of language I think is kind of a Freudian slip. It's us seeing into his mind. And, you know, what it reveals is that this gentleman has purported to be an advocate for humanity, the champion of global health, is working another agenda. Why else would he say, “sadly”, that this natural phenomena of Omnicom is acting as a natural vaccine and has virtually vaccinated the entire world to generate mucosal immunity. Exactly what I predicted. If anybody wants to fact check me, they all I got to do is look up the Laura Ingram clips from before Christmas.
Frankly I went out line on that prediction. I was a little worried that I was going a little too far. But the thing about being a professional and doing this for a living for decades is it gives you a certain amount of confidence in reading the data and as a virologist and a vaccinologist, I knew when I heard the data coming out of South Africa that this looked like it could play out in a good way. When I looked at how the virus had evolved to infect upper airways. So I said that this looked like a Christmas present.
And now we've got Bill Gates confirming it, in his own interesting way, which which reveals his own personal agenda. But I again, I really don't like to get into people's heads. I'm not a psychiatrist. Yeah, but it's a fascinating statement.
Art Moore
Yeah. Just one thing really quickly to add, I think to that a Dr. Cole, you've been talking about natural immunity and its superiority. The studies show us over vaccine immunity. So when we talk about Omicron being like a natural vaccine, that's pretty good news.
Dr. Ryan Cole
That's fantastic news. Brownstone Institute has 150 articles showing how natural immunity is far superior to vaccine immunity. And we've known this for a long time. Omicron is, to Dr. Malone's point, even even more so that added blessing to humanity as this virus has changed and is our new “Funny Uncle” Variant. It is less deadly than earlier variants but spreads more readily. Natural immunity has provided that broad natural immunity. COVID recovered immunity has mucosal immunity. Now when it comes into your body, your body says, “Hey, I remember that I can fight that off.” So yeah, it's a blessing to humanity. We've been saying this for a long time. And now the data is supporting that.
Dr. Robert Malone
There is one nuance in the current data that that is a little worrisome. And I'm not comfortable that it is fully verified yet. But the signal is there and it's very worrisome to many of us.
There is data from all over the world coming direct from government databases suggesting that the risk of the current infection and disease is higher in people that have been previously vaccinated. And it's a function of the number of doses. So this gets to a whole issue of whether it makes a lot of sense to keep boosting people, because this is it.
The risk of enhanced disease and infection is still here. That is something the FDA worried about in their very first emergency use authorization documents. They told the pharmaceutical industry that they had to follow this issue and analyze whether or not it was happening. Pharma decided not to do that, even though the FDA recommended it. And the FDA didn't force them to do it.
And now we're seeing the signal. So that's the thing that I think got both of us a little bit worried is these signs exist and the concern is that we may see future variants. We have to be very vigilant right now. But this knee jerk reaction to just do more vaccination has significant risk for making things worse rather than better.
Dr. Ryan Cole
And we knew this historically with the trials of prior coronavirus vaccines, which all failed for pathologic and immunologic reasons. And we know the history of this family of viruses. So kind of to your original question, was a vaccine strategy the prudent thing to do well, in retrospect and to Dr. Malone's point that we know that more doses doesn't seem to be helping, it rather seems to be having a detrimental effect on those who have had more doses in terms of acquisition of future variants and adverse outcomes with those variants.
So our concern is from a pattern point of view that and that the CDC is hiding the data. They know that this is an issue and the point of this conversation.
Dr. Robert Malone
Well, and then there's then there's this chief immunologist in Israel, which is ground zero for rolling out the Pfizer vaccine with the extra booster. You talked about that.
Dr. Ryan Cole
This is key. Dr. Cohen, the chief immunologist of Israel, who created their vaccine roll out program. Not they have given shot after shot and booster with another booster. Dr. Cohen now says, “look we've made mistakes. We thought this was going to be better than it was with these shots. That there would be no more passports, no more boosters. It is not working.”
If you want to see where diseases going off the charts, look at where they've received a third and a fourth booster that's Israel.
So their chief immunologist is saying “stop, we have to stop.” Of course the media attacked him for saying it but he has the data and the science saying this is prudent time to stop.
Dr. Robert Malone
And if I can't know there's another buried lead in that bill Gates interview. He acknowledges that they blew it by suppressing early treatment and drug alternatives and just focusing on the vaccines. It's a fascinating interview. And that's another message that our group has been putting out through Dr. Peter McCullough and Dr. Dr. Zelenko and so many other doctors - that early treatment saves lives.
And now we got Bill Gates, the champion of vaccines, acknowledging that the public health community worldwide blew it by suppressing early treatment. And by the way, one of the ways they've suppressed it is through this propaganda campaign in the press that we've seen both on hydroxychloroquine and ivermectin early treatment, They have blocked papers about early treatment in the scientific literature, and most scientific journals requiring that there be these little statements genuflecting to the efficacy of the vaccine if you want to publish anything.
But now the data is coming out anyway.
Art Moore
Is that in line with this whole idea of the vaccines or the way to do this? And if you have alternative treatments, I understand you can't get emergency use authorization because that's one of the criteria.
Dr. Robert Malone
There is that. The problem with that argument is that I tested that directly with the CDC and asked them to get back to me. And they did. And basically, they said yeah, that's the way the law reads. But they said to me directly, they don't care they're going to do whatever they want to do. They disregarded the actual language of the emergency use authorization.
So they didn't really see that as an obstacle. That gets to this whole point of what is functionally under this emergency declaration that has just been reactivated by the Biden administration. They're able to suspend law. At least they believe that they are. They believe that they're able to circumvent the Constitution and the statutes enacted by Congress, including the bioethics statutes that we call the common rule.
That has been one of the things that's upset me the most all the way through this is the government is acting in a lawless fashion, and they believe they have the right to do it because of this emergency declaration, which in our opinion is no longer valid. There is no medical emergency here. So if there's any emergency, it's that the truckers are rolling on DC that's what's got them really worried.
Dr. Ryan Cole
There is no medical emergency now that Omicron is here, acting as a blessing for humanity. We know we have early treatments. We know how to stop the disease and treat the disease. So to declare that there's a medical emergency is pure governmental fraud. We as physicians and tens of thousands of physicians know that this no that that declaration of emergency is fraudulent.
So they are violating constitutional principles and the law. We know the CDC is lying to us. Now, who else was lying to us? This is the frustration in all of this, is that we are the scientists. We see the disease. We know what's happening. The truth needs to be told that there is no emergency. The emergency powers need to end yesterday.
And we support those who use their constitutional rights to protest for freedom. We are all truckers now.
Dr. Robert Malone
Well put.



LINK TO VIDEO ON RUMBLE:
Dr. Robert Malone and Dr. Ryan Cole: CDC committing 'scientific fraud'
Published February 22, 2022
31 min 48 sec
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Follow the Data, They Said, and Then Hid It
By Jeffrey A. Tucker February 24, 2022 Policy, Vaccines 6 minute read

Never before has the public had access to so much data on a virus and its effects. For two years, data festooned the daily papers. Dozens of websites assembled it. We were all invited to follow the data, follow the science, and observe as scientists became our new overlords, instructing us how to feel, think, and behave in order to “flatten the curve,” “drive down cases,” “preserve capacity,” “stay safe,” and otherwise deploy all the powers of human will to respond to and manipulate disease outcomes.

We could watch it all in real time. How beautiful were the waves, the curves, the bar charts, the sheer power of the technology. We can look at all the variations and the trajectories, assemble them by country, click here and click there to compare, see new cases, total cases, unvaccinated and vaccinations, infections and hospitalizations, deaths in total or death per capita, and we could even make a game out of it: which country is doing better at the great task, which group is better at complying, which region has the best outcomes.

It was all quite dazzling, the power of the personal computer combined with data collection techniques, universal testing, instant transmission, and the democratization of science. We were all invited to participate from our laptops to bone up on statistics, download and look, assemble and draw, manipulate and observe, and be in awe of the masters of the numbers and their capacity for responding to every trend as it was captured and chronicled in real time.

Then one day, writing at the New York Times, reporter Apoorva Mandavilli revealed the following:

For more than a year, the Centers for Disease Control and Prevention has collected data on hospitalizations for Covid-19 in the United States and broken it down by age, race and vaccination status. But it has not made most of the information public…. Two full years into the pandemic, the agency leading the country’s response to the public health emergency has published only a tiny fraction of the data it has collected, several people familiar with the data said.
Kristen Nordlund, a spokeswoman for the C.D.C., said the agency has been slow to release the different streams of data “because basically, at the end of the day, it’s not yet ready for prime time.” She said the agency’s “priority when gathering any data is to ensure that it’s accurate and actionable.”
Another reason is fear that the information might be misinterpreted, Ms. Nordlund said.

At the appearance of this story, my data science friends who have been digging through the databases for nearly two years all let a collective: argh! They knew something was very wrong and had been complaining about it for more than a year. These are sophisticated people at Rational Ground who keep their own charts and host data programs of their own. They have been curious all along about the exaggerations, the poor communication regarding the gradients of risk, the lags and holes in the demographic data on hospitalization and death, to say nothing of the strange way in which the CDC has been manipulating presentations on everything from masking to vaccination status and much more.

It’s been a strange experience for them, especially since other countries in the world have been absolutely scrupulous about collecting and distributing data, even when the results do not comport with policy priorities. There can be little doubt, for example, that the missing data bears on the issue of vaccine effectiveness and very likely demonstrates that the claim that this was a “pandemic of the unvaccinated” is completely unsustainable, even from the time when it was first made.

In the New York Times story, many top epidemiologists were quoted expressing everything from frustration to outrage.

“We have been begging for that sort of granularity of data for two years,” said Jessica Malaty Rivera, an epidemiologist and part of the team that ran Covid Tracking Project, an independent effort that compiled data on the pandemic till March 2021. A detailed analysis, she said, “builds public trust, and it paints a much clearer picture of what’s actually going on.”

Well, if public trust is the goal, it’s not going so well. In addition to the failings revealed here, there are many other questions concerning cases and whether and to what extent the PCR testing can really tell us what we need to know, to what degree did the misclassification problem affect death attribution, and so much more. It seems that with each month that has gone by, what seemed to be these beautiful pictures of reality have faded into a murky data quagmire in which we don’t know what is real and what is not. And ever more, the CDC itself has urged us to ignore what we do see (VAERS data, for example).

Dr. Robert Malone makes an interesting point. If a scientist at a university or a lab is found to have deliberately buried relevant data because they contradict a preset conclusion, the results are professional ruin. The CDC, however, has legal privileges that allows it to get away with actions that would otherwise be considered fraud in academia.

There are many analogies between economics and epidemiology, as many have noticed over the last two years. The attempt to plan the economy in the past has suffered from many of the same failures as the attempt to plan a pandemic.

There are collection problems, unintended consequences, knowledge problems, issues of mission creep, uncertainties over causal inference, a presumption that all agents obey the plan when in fact they do not, and a wild pretense that planners have the necessary knowledge, skill, and coordination required to presume to replace the decentralized and dispersed knowledge base that makes society work.

Murray Rothbard called statistics the Achilles heel of economic planning. Without the data, economists and bureaucrats couldn’t even begin to believe they could achieve their far-flung dreams, much less put them into practice. For this reason, he favored leaving all economic data collection to the private sector so that it is actually useful for enterprise rather than abused by government. In addition, there is simply no way that data alone can provide a genuine full picture of reality.

There will always be holes. It will always be late. There will always be mistakes. There will always be uncertainties over causality. Moreover, all data represents a snapshot in time and can prove extremely misleading with changes over time. And these can be fatal for decision making.

We are seeing this play itself out in epidemiological planning too. The endless streams of data over two years have created what Sunetra Gupta calls “the illusion of control” when in fact the world of pathogens and its interaction with the human experience is infinitely complex. That illusion also creates dangerous habits on the part of planners, which we’ve seen.

There was never a reason to close schools, lock people in their homes, block travel, shut businesses, mask kids, mandate vaccines, and so on. It’s almost as if they wanted human beings to behave in ways that better fit their own modeling techniques rather than allow their knowledge base to defer to the complexity of the human experience.

And now we know that we’ve been denied information that the CDC has kept in hiding for the better part of a year, undoubtedly to serve the purpose of forcing the appearance of reality to more closely conform to a political narrative. We only have a fraction of what has been accumulated. What we thought we knew was only a glimpse of what was actually known on the inside.

There is no shortage of scandals associated with pandemic policy over two years. For those who are interested in finding out precisely what caused the lights to be dimmed or even turned out on modern civilization, we can add another scandal to the list.
.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Vitamin D2's impact on human health questionable, but vitamin D3 could be important for fighting infections
by University of Surrey
February 24, 2022

1645773243968.jpeg
Protein-protein interaction networks for gene products corresponding to the probes (A) significantly down-regulated or (B) significantly up-regulated in both the D2 and D3 treatment groups of the WE cohort, but not the placebo group. Details given in Supplementary Data File 3. The networks were generated using the STRING database of Homo sapiens medium confidence (0.4) interactions, and only connected nodes are shown. Networks for both (A, B) are significantly enriched for interactions compared to randomized sets, yielding p-values of 1.98 × 10-6 and 4.99 ×10-9, respectively. Credit: DOI: 10.3389/fimmu.2022.790444

New research has found significant differences between the two types of vitamin D, with vitamin D2 having a questionable impact on human health. However, the study found that vitamin D3 could balance people's immune systems and help strengthen defenses against viral infections such as COVID-19.

In a collaborative study by the Universities of Surrey and Brighton, researchers investigated the impact of vitamin D supplements—D2 and D3—taken daily over a 12-week period on the activity of genesin people's blood.

Contrary to widely held views, the research team discovered that both types of vitamin D did not have the same effect. They found evidence that vitamin D3 had a modifying effect on the immune system that could fortify the body against viral and bacterial diseases.

Professor Colin Smith, lead-author of the study from the University of Surrey, who began this work while at the University of Brighton, said:

"We have shown that vitamin D3 appears to stimulate the type I interferon signaling system in the body—a key part of the immune system that provides a first line of defense against bacteria and viruses. Thus, a healthy vitamin D3 status may help prevent viruses and bacteria from gaining a foothold in the body.

"Our study suggests that it is important that people take a vitamin D3 supplement, or suitably fortified foods, especially in the winter months."

Although some foods are fortified with vitamin D, like some breakfast cereals, yogurts, and bread,fewnaturally contain the vitamin. Vitamin D3 is produced naturally in the skin from exposure to sunlight or artificial ultraviolet UVB light, while some plants and fungi produce vitamin D2.

Many people have insufficient levels of vitamin D3 because they live in locations where sunlight is limited in the winter, like the UK. The COVID-19 pandemic has also limited people's natural exposure to the sun due to people spendingmore time in their homes.

Professor Susan Lanham-New, co-author of the study and Head of the Department of Nutritional Sciences at the University of Surrey, said:

"While we found that vitamin D2 and vitamin D3 do not have the same effect on gene activity within humans, the lack of impact we found when looking at vitamin D2 means that a larger study is urgently required to clarify the differences in the effects. However, these results show that vitamin D3 should be the favored form for fortified foods and supplements."

The study has been published in Frontiers in Immunology.

More information: Louise R. Durrant et al, Vitamins D2 and D3 Have Overlapping But Different Effects on the Human Immune System Revealed Through Analysis of the Blood Transcriptome, Frontiers in Immunology (2022). DOI: 10.3389/fimmu.2022.790444
Journal information: Frontiers in Immunology

Provided by University of Surrey
 

Heliobas Disciple

TB Fanatic
(fair use applies)



As 'stealth omicron' advances, scientists are learning more
by Laura Ungar
February 24, 2022

The coronavirus mutant widely known as stealth omicron is now causing more than a third of new omicron cases around the world. But scientists still don't know how it could affect the future of the pandemic. Credit: NIAID/NIH via AP, File

The coronavirus mutant widely known as "stealth omicron" is now causing more than a third of new omicron cases around the world, but scientists still don't know how it could affect the future of the pandemic.

Researchers are slowly revealing clues about the strain, a descendant of omicron known as BA.2, while warily watching it become ever more prevalent.

"We're all keeping an eye on BA.2 just because it has done particularly well in some parts of the world," including parts of Asia, Africa and Europe, said Dr. Wesley Long, a pathologist at Houston Methodist in Texas.

This week, a technical advisory group for the World Health Organization advised public health authorities to monitor it as a distinct omicron strain.

Early research suggests it spreads faster than the original omicron and in rare cases can sicken people even if they've already had an omicron infection. There's mixed research on whether it causes more severe disease, but vaccines appear just as effective against it.

Overall cases are falling in some places where the variant is becoming more prevalent, offering some hope that the latest troubling version of the virus won't send cases skyrocketing again as experts try to learn more.

WORLDWIDE SPREAD

BA.2 has been found in more than 80 countries and all 50 U.S. states.

In a recent report, the WHO said BA.2 was dominant in 18 countries and it represented about 36% of sequenced omicron cases submitted in the most recent week to a publicly available international database where scientists share coronavirus data. That's up from 19% two weeks earlier.

In the United States, BA.2 caused about 4% of COVID cases during the week ending Feb. 19, according to the Centers for Disease Control and Prevention. The percentage was lower in some regions and higher in others – hitting about 7% in New England.

WHAT'S KNOWN

BA.2 has lots of mutations. It's been dubbed "stealth" because it lacks a genetic quirk of the original omicron that allowed health officials to rapidly differentiate it from delta using a certain PCR test. So while the test can detect a BA.2 infection, it looks like a delta infection.

Initial research suggests BA.2 is more transmissible than the original omicron—about 30% more contagious by one estimate.

But vaccines can protect people from getting sick. Scientists in the United Kingdom found that they provide the same level of protection from both types of omicron.

A bout with the original omicron also seems to provide "strong protection" against reinfection with BA.2, according to early studies cited by the WHO.

But getting BA.2 after infection from the original omicron strain is possible, says new research out of Denmark. Study authors noted 187 total reinfections, including 47 with BA.2 occurring shortly after a bout the original strain, mostly in young, unvaccinated people with mild disease. They concluded that such reinfections do occur but are rare. Like other early studies on BA.2, this one has been posted online but not reviewed by independent scientists.

DOES BA.2 MAKE YOU SICKER?

A Japanese lab study suggests that it could, based on experiments with hamsters. Researchers concluded that the risk for global health "is potentially higher" from BA.2 and proposed that it be given its own Greek letter – a designation for globally significant "variants of concern." WHO's technical group said BA.2 should remain under the omicron umbrella.

Though the severity experiments were conducted in animals, the study is "not something to discount," said Dr. Eric Topol of Scripps Research Translational Institute. "We should keep an open mind and keep assessing this."

But scientists are finding something different when they look at people. An initial analysis in Denmark showed no differences in hospitalizations for BA.2 compared with the original omicron, which tends to generally cause milder disease than the delta variant. More recently, researchers in South Africa found much the same: a similar risk of hospitalization and severe disease with the original omicron variant and BA.2.

"We always have to interpret studies in animals with caution," Long said. "I place more weight in studies of actual patients and what they're experiencing."

HOW WILL BA.2 AFFECT THE PANDEMIC?

No one knows for sure.

COVID-19 cases are dropping globally, including in some of the places where BA.2 is prevalent.

"The timing of the upswings and downswings in cases remains unclear," said Louis Mansky, director of the Institute for Molecular Virology at the University of Minnesota.

It's difficult for researchers to predict how much BA.2 will change caseloads because it is spreading in communities with varying levels of protection from vaccines and prior infections. Some experts believe BA.2 is unlikely to spark new surges but may slow COVID declines in some places.

WHO officials stress that the pandemic isn't over and urge countries to remain vigilant.

Doctors said individuals should do the same and remember that vaccines and boosters offer excellent protection against the worst effects of COVID-19, no matter the variant.

"For people who aren't boosted, please get boosted. For people who aren't vaccinated, it's never too late," Long said. "Your best defense against COVID is still the vaccine."


Explore further What COVID-19 experts know about new Omicron BA.2 subvariant
 

Heliobas Disciple

TB Fanatic
(fair use applies)

CDC to significantly ease pandemic mask guidelines Friday
By ZEKE MILLER
today

WASHINGTON (AP) — The Biden administration will significantly loosen federal mask-wearing guidelines to protect against COVID-19 transmission on Friday, according to two people familiar with the matter, meaning most Americans will no longer be advised to wear masks in indoor public settings.

The Centers for Disease Control and Prevention on Friday will announce a change to the metrics it uses to determine whether to recommend face coverings, shifting from looking at COVID-19 case counts to a more holistic view of risk from the coronavirus to a community. Under current guidelines, masks are recommended for people residing in communities of substantial or high transmission — roughly 95% of U.S. counties, according to the latest data.

The new metrics will still consider caseloads, but also take into account hospitalizations and local hospital capacity, which have been markedly improved during the emergence of the omicron variant. That strain is highly transmissible, but indications are that it is less severe than earlier strains, particularly for people who are fully vaccinated and boosted. Under the new guidelines, the vast majority of Americans will no longer live in areas where indoor masking in public is recommended, based on current data.

The new policy comes as the Biden administration moves to shift its focus to preventing serious illness and death from COVID-19, rather than all instances of infection, as part of a strategy adjustment for a new “phase” in the response as the virus becomes endemic.

The two people familiar with the change spoke on the condition of anonymity to preview the CDC’s action before the announcement.

The change comes as nearly all U.S. states that had put in place indoor mask-wearing mandates for the winter omicron surge are letting them lapse as cases have precipitously dropped nationwide. Some have eliminated the mandates entirely, while others have kept mask-wearing requirements in place for schools and medical facilities.

It was not immediately clear how the new CDC guidance would affect U.S. federal mandates requiring face coverings on public transportation.

The CDC’s director, Dr. Rochelle Walensky, has said a change has been in the works.

“We must consider hospital capacity as an additional important barometer. Our hospitals need to be able to take care of people with heart attacks and strokes. Our emergency departments can’t be so overwhelmed that patients with emergent issues have to wait in line,” she said during a White House briefing last week.

However, she declined to give a specific day when the CDC would announce a change. CDC officials on Thursday refused to confirm a release date.

“At @CDCgov, we have been analyzing our #COVID19 data and shifting our focus to preventing the most severe outcomes and minimizing healthcare strain,” Walensky tweeted Thursday night, offering no details on Friday’s announcement.
.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

CDC to update masking guidance as soon as Friday
11 hours ago
Caitlin Owens



The CDC plans to announce as soon as tomorrow that it has created new metrics for determining when people should use masks and take other COVID precautions, according to sources familiar with the plan, including a source involved in developing the system.

Why it matters: The new metrics would allow less masking for most of the U.S. population, and would suggest universal masking only in places being hit hardest by the virus.

State of play: The CDC has developed the new benchmarks over the last six weeks or so, the source said, as Omicron hit the U.S. and then receded.
  • The goal is to move away from using case counts alone to determine when to mask and take other precautions, like distancing or avoiding high-risk settings.
  • Currently, the CDC recommends universal indoor masking in areas of substantial or high transmission, which includes the vast majority of U.S. counties.
The new benchmarks will instead tie masking recommendations to a combination of a community's level of cases, hospitalizations and hospital capacity, the source said.
  • The CDC is basing its updated benchmarks on data from previous surges as well as modeling.
Between the lines: As vaccination and booster rates have risen, case counts have become an increasingly less meaningful measure of the severity of the pandemic. Many experts argue that hospitalizations and the amount of severe cases are much better indicators of how serious an outbreak is.

Yes, but: The new guidance may not have much of a practical impact for many Americans.
  • Many cities and states have already lifted their mask mandates as Omicron subsides — and plenty more haven't had a mask mandate for a long time, if ever.
.
 

ainitfunny

Saved, to glorify God.
IMO- Asking CHILDREN to wear masks ALL DAY is begging for a wave of MENTAL RETARDATION as brain cells DIE for lack of oxygen because these masks do not freely pass OXYGEN once they get WET with moisture from breath! If you want to make children wear masks and DONT WANT THEM GETTING DUMBER BY THE DAY, MAKE SURE YOU GIVE THEM A FRESH, DRY MASK HOURLY! Or at least when they are starting to get wet.
 
Last edited:

Heliobas Disciple

TB Fanatic
Here's another article from Profit of Doom. If anyone else is on a phone and has an article that is too long or difficult to copy over, please post a link or pm me (or marsh - looking forward to more posts from marsh!) and I'll post the article for you.

(fair use applies)

Pfizer & Moderna Investors Run for the Exits
Justus R. Hope, MD
Feb 21, 2022 Updated Feb 23, 2022


Wall Street investors are dumping their Moderna and Pfizer stock faster than the world can drop the mandates. Moderna is down 70 percent from its high, while Pfizer is off 19 percent. Former Blackrock Executive and investment adviser Edward Dowd calls for Moderna to go to zero and Pfizer to end under ten dollars per share.

How is this possible given that Pfizer now enjoys record earnings per share and a market capitalization of some $270 billion, making it the 29th largest corporation globally? With nothing but profits in sight for the Pharmaceutical giant, what could be the problem?

After all, in December, a Forbes' headline read, "The Vaccine Maker Can Dominate The Covid Market For Years to Come, Wells Fargo Predicts." In addition to the enormously profitable mRNA vaccines, Pfizer is rolling out potent antivirals like Paxlovid, which could earn $22 billion in 2022.

This Vaccine Maker Can ‘Dominate’ The Covid Market For Years To Come, Wells Fargo Predicts

Compared to the $81 billion in 2021 revenue, the earnings from the vaccines and the antivirals could top $102 billion for 2022, which is music to shareholders' ears. However some are hearing shrieks, and these happen to be Wall Street's finest, the smart money that beats the rest of the herd to the exits like clockwork.

These sophisticated investors make it their business to not go with the conventional wisdom but to do their own research, which often pays spectacular dividends.

Edward Dowd is one such investor. He saw the dot com bubble ready to burst and acted accordingly. But, unfortunately, other not-so-savvy investors later saw their dot com heavy portfolios collapse as the NASDAQ Composite Index lost 40% of its value in 2000.

Dowd, a graduate of Notre Dame University and former Portfolio Manager at Blackrock, grew his fund from $2 billion to $14 billion and commanded the respect of his investment community peers.

Today, after semi-retiring to the shores of South Maui, he remains a voice of stock market wisdom that many hedge funds continue to rely upon. LinkedIn lists him as a Consultant to Founder & Partner of Symphonic Capital, LLC.

But the dot com collapse is not the only one Dowd successfully navigated. While many other portfolio managers placed their client's money in highly rated and lucrative mortgage-backed securities, Dowd hesitated and questioned. He considered that those might be grossly over-rated, and he was correct.

It turns out that the mortgage rating system was corrupted by the high profitability of predatory financial products tied to home mortgages. According to Edward Dowd, a large portion of the blame was shouldered by the rating agencies, those trusted organizations whose job it was to judge the risk of these subprime mortgage-backed securities – agencies like Moody’s, Standard & Poor’s and Fitch.

Dowd says they turned a blind eye to the true risk because it was profitable. So, in essence, these rating agencies were captured by the institutions backing these risky subprime securities.

Moody's $864m penalty for ratings in run-up to 2008 financial crisis

Joseph Stiglitz, a Nobel Prize-winning economist, put it this way, "The incentive structure of the ratings agencies also proved perverse. Agencies such as Moody's and Standard & Poor's are paid by the very people they are supposed to grade. As a result, they've had every reason to give companies high ratings, in a financial version of what college professors know as grade inflation."

Joseph E. Stiglitz on capitalist fools

Dowd has sounded the alarm on Moderna and Pfizer as sinking ships that investors need to abandon. So what does the man who foresaw the dot com and the subprime mortgage crisis have to say about Moderna and Pfizer, and what trouble could exist in the paradise of COVID vaccine profits?

Here are Dowd’s words:

I want to liken here to what's gone on in the Great Financial Crisis. We had rating agencies, third-party verification sources that were able to perpetuate the fraud because the money got too big, their institutions became corrupted with the institutional imperative, and they got triple-A ratings which we all know in hindsight were not triple-A ratings – let's move forward to today.
The FDA is the trusted third-party verification of pharmaceutical products. 50% of their budget comes from Pharma...due to the institutional imperative that was in place at the time and the speed with which they tried to approve these unproven products with this unproven technology, fraud did occur, and what's my proof of that? The FDA, together with Pfizer, were trying to hide the clinical data.
And it’s come out recently...that the all-cause mortality for the Pfizer product failed – that means there were more deaths in the vaccine group than the placebo group. Normally in such a case, you have NO drug approval for such drugs. It's the gold standard. I've been told by all my people in the Biotech Industry they were horrified... See mark 25:10.​

Episode 1,602 – The Big Short - Pfizer & Moderna: the New Enron; Are Criminal Charges Defensible? (w/ Rep. Claudia Tenney, Ben Harnwell, Dr. Robert Malone, Edward Dowd, Thomas Renz) - Bannon's War Room | iHeart

And unfortunately, that is not all. Dowd feels that although he has successfully predicted three large frauds in his career, he now expects a global financial market collapse with the debt bubble getting ready to burst.

“So I’ve seen three frauds; the corporate fraud of the dot com boom, the bank fraud of the Great Financial Recession, and
I believe the fraud has moved on to central banks and governments – because that’s the nature of our monetary system – you have to constantly create credit to keep this thing going.” See mark 2:22.
Former Executive of BlackRock Edward Dowd

“The global debt bubble is at its peak…we are at the end…we are going to see lots of crazy things in the financial markets…we are going to see the credit markets become unhinged, the equity markets become unhinged. The Fed got a reprieve…under the cover of COVID, they were able to print 65% more money to keep this thing afloat, but we are at the end days here.” See mark 3:41.

Former Executive of BlackRock Edward Dowd

He clarifies that the emergence of global totalitarianism is not purely about power and profit. Instead Dowd feels it is to control the masses when they realize the economy is collapsing – the ramifications of which may be the loss of pensions and social security income.

“A lot of what you are seeing in the response of global governments is setting up a system – under the guise of medical tyranny – to prevent the riots that are going to ensue once this thing all unwinds – that’s my personal belief…” See mark 4:04.

Former Executive of BlackRock Edward Dowd

For the skeptics, consider that Pfizer stock lost $20 billion in market capitalization on February 8, 2022, when their record earnings fell short of more optimistic expectations.

Pfizer Triggers $28 Billion Stock Plunge After Warning Covid Vaccine Sales May Disappoint This Year

Also consider that Moderna's stock is down some 70 percent from its high of $484 on August 9, 2021, wiping out almost $ 140 billion in investment.

Moderna Stock Crash: Losses Top $140 Billion As Insiders Sell Millions Of Dollars In Shares

Dowd predicts Moderna will drop to zero with bankruptcy as fraud related to concealing the COVID vaccine dangers surfaces, and he predicts Pfizer will become a sub-ten-dollar stock. Dowd explains that the smart money has already left Moderna and will soon be exiting Pfizer.

Dowd foresees an avalanche of lawsuits coming as the insurance industry continues to uncover the legions of mounting deaths coming from the complications of the mRNA COVID-19 vaccines.

Dowd teamed up with an insurance industry analyst and researched the life insurance claims. They found that since OneAmerica shocked the world by announcing a 40% rise in non-COVID deaths in younger working-class employees, multiple other insurance companies worldwide have seen the same thing – massive rises in non-COVID deaths. And the evidence inescapably points to the vaccines as the cause. See mark 13:16.

Edward Dowd on Wall Street and Pfizer

Life insurance deaths up 40% - Dr. Robert Malone’s chilling analysis

Meanwhile, the funeral company stocks have outperformed the S&P. “Funeral Home companies are growth stocks. They had a great year in 2021 compared to 2020, and they outperformed the S&P 500. The peer group of Funeral Home stocks was up 40 plus percent while the S&P was up 26 percent – and they started accelerating price-wise in 2021 during the roll-out of the vaccines – You don’t need to be a rocket scientist to connect the dots here.” See mark 5:55.

Edward Dowd on Wall Street and Pfizer

Other insurance companies have reported the same or worse death numbers as OneAmerica. For example, “Unum Insurance is up 36%, Lincoln National plus 57%, Prudential plus 41%, Reinsurance Group of America plus 21%, Hartford plus 32%, Met Life plus 24%, and Aegon – which is a Dutch insurer – saw in their US arm plus 57% in the 4th quarter – in the 3rd quarter they saw a 258% increase in death claims.” See mark 07:55.

Edward Dowd on Wall Street and Pfizer

“They raised (mortality) expectations 300,000 for 2022 over 2021 due to COVID plus 'indirect COVID,' which I think we know what that’s code for... They (Aegon) did a $1.4 billion reinsurance deal with Wilton Reinsurance…what they were reinsuring were high face amount individual policies from 1 million to 10 million… (So) I think there is an asymmetric information situation going on in the insurance industry where some people have figured out something’s going on. They are off-loading their risk – they are not going to say what it is as they don’t want that information to get out as they unload the risk.” See mark 08:49.

Edward Dowd on Wall Street and Pfizer

[CONTINUED]
 

Heliobas Disciple

TB Fanatic
CONTINUED

"Someone is going to be the bag holder here." And Dowd is confident it won't be the insurance industry. A court in France has already held that a life insurance company cannot be held liable for a death because of the mRNA vaccine.

Life insurer refuses to cover vaccine death | Free West Media

But that does not explain how mRNA manufacturers can be held responsible for an emergency product they were told was liability-free. Aren't the vaccine manufacturers immunized from lawsuits?

After all, they were granted EUA, the specialized Emergency Use Authorization, which means they cannot be held legally accountable for deaths or adverse effects stemming from the experimental vaccines.

The idea is that no company – upon government request – should have to pay for unforeseen complications resulting from an emergency product that they released to the world out of their goodness of the hearts, with the best of intentions. Right?

Wrong – not when your company accomplishes this through deceit, also known as fraud.

Fraud undoes all these protections. If a company or person intentionally deceives another to profit, we have fraud. If Pfizer’s data showed increased all-cause mortality and hid this to motivate people to take the vaccine while claiming it was safe, then fraud exists.

Under common law, the required elements to prove fraud amount to:

#1. A materially false statement or purposeful failure to state or release material facts which non-disclosure makes other statements misleading.
#2. The false statement is made to induce Plaintiff to act.
#3. The Plaintiff relied upon the false statement, and the injury resulted from this reliance.
#4. Damages include a punitive award as a punishment that serves as a public example to discourage any future similar fraud. Punitive damages are generally proportional to the Defendant's assets.
Fraud Law and Legal Definition | USLegal, Inc.

Dowd has been researching the COVID-19 vaccines and what he considers obvious evidence of knowing concealment of the actual risks of death – and he points to the Herculean efforts of Pfizer with FDA in withholding their data despite legal challenges to release it. He likens the FDA today to the rating agencies during the Mortgage Crisis.

"FDA is the trusted third party, just like the rating agencies were. And a lot of doctors in this country, a lot of local governments are placing their trust in the FDA which gets 50 percent of its budget from large cap pharma. It wasn't any one person...I think they overlooked things...An all-cause mortality end-point should have stopped this thing in its tracks – and it didn't." See mark 1:51.

View: https://twitter.com/Sander_2021/status/1489746293002022912?s=20&t=nb7l5w4vfRvJsJ7TFfHyiQ

There were more deaths in the vaxxed group than in the unvaxxed. Dowd assumes fraud based upon the FDA backing Pfizer in not releasing their data. He believes this is a knowing attempt to conceal the deaths.

“When one party enters into a contract…and fraud was occurring when they entered into that contract, and the other party did not know that – the contract is void and null. There’s no indemnity if this can be proven, and I think it will be.” See mark 4:45.

Edward Dowd on Wall Street and Pfizer

"Pfizer got blanket immunity with EUA. If fraud occurred, to my mind and what I'm seeing from their refusal to release the data – if there is fraud and it comes out – and we need whistleblowers – and it's looking more apparent that this product is deadly –fraud eviscerates all contracts – that's case law. So you go down the daisy chain, and that’s liability – that's bankruptcy for Moderna, definitely Pfizer." See mark 00:51.

View: https://twitter.com/Sander_2021/status/1489746293002022912?s=20&t=mNqs_wz572WqybdulzaK7A

Dowd remarks that no matter the effort, one cannot hide the bodies – and “the bodies are piling up.” See mark 12:56.
Edward Dowd on Wall Street and Pfizer

He notes that the deaths skyrocketed after the vaccine rollout when they should have dropped. And the deaths are what distinguished the 2021-2022 vaccine scandal as far worse than what happened with Enron.

"People are dying and being maimed. This is a fraud that goes beyond the pale...We have the VAERS data...We have the DoD leak...And now we have the insurance company results and the funeral home results...We don't need to think too hard about this...Deaths should have gone down after the vaccines rolled out. This is the most egregious fraud in history of the nation – and it's global...Pfizer's involved, and they committed fraud," Dowd explained. See mark 10:25.

Edward Dowd on Wall Street and Pfizer

"My job is to be ahead of the news and be a lead steer...when I use my stock picking skills outside the realm of stock picking, I am called a conspiracy theorist." See mark 6:45.

Edward Dowd on Wall Street and Pfizer

Dowd emphasized that he is not short on Pfizer or Moderna stock. He explained that he does not profit from their share prices dropping. He also points out that his predictions are not the cause of the steep declines as these occurred before he came out with this analysis. See mark 13:45.

Former Executive of BlackRock Edward Dowd

"Let me make a point here. The mainstream media may ignore this. Wall Street is not." See mark 2:16.

Edward Dowd on Wall Street and Pfizer

"This is the most interesting hallucination I've ever seen in the financial markets." See mark 12:06.

Former Executive of BlackRock Edward Dowd

"So we don't need the mainstream media...And I want you to know – Wall Street is rallying to this – I'm getting lots of inquiries from former colleagues. Nothing will convince a sleeping public more than red stocks or collapsing stocks. My goal is to awaken the country by seeing something is going on. And Wall Street is AWAKE!" See mark 2:33.

Edward Dowd on Wall Street and Pfizer

If money is any indicator, Edward Dowd is correct that insurance will win a fight between the insurance and the vaccine industries. The life insurance market in the US is worth some $900 billion, while the vaccine market pales in comparison.

COVID-19 vaccine market set to reach $19.5bn by 2026 – register for free webinar

IBISWorld - Industry Market Research, Reports, and Statistics

If someone is left holding the bag, it will not be the insurance industry, but it just might be you and me, the average citizen. However, there is one major caveat – if Edward Dowd succeeds in awakening the citizens, then they – the oligarchs – cannot get away with this – the Vaccine Fraud, the Great Reset, the Fourth Industrial Revolution and Global Totalitarianism.

Gates, Fauci, and Daszak charged with Genocide in Court Filing

Amazon.com

"There's lots of people who got the jabs that didn't understand what was going on. A lot of them are in the investment world. A lot of them are smart people – they were duped too. Some of these people that got the jab are doing the work on shorting these stocks because – you know, you can guess – because they are mad as hell – and you've awakened the sleeping giant known as Wall Street. And Wall Street is on the move. The smart money is moving first – as always there's lead steers. Nothing gets going faster than a red momentum down-trending stock.” See mark 3:26.

Edward Dowd on Wall Street and Pfizer

Those of you who still think nothing's going on, you don't want to be – what I call – the bag holder. You don't want to be the guy taking the fourth jab booster and holding these stocks (on their way) down – Moderna's going to zero – I think Pfizer goes sub ten dollars once the lawsuits come out. " See mark 4:06.

Edward Dowd on Wall Street and Pfizer

Dowd’s forecast can awaken not only Wall Street but the ordinary citizen. We are those sleeping giants of the world, those who can move mountains with the force of our stock sales and non-violent protests, the great silent majority who can remove dictators from power and elect new and fair leaders.

There is power in numbers, as the Canadian Truckers recently found. Courage is contagious as freedom convoys have sprung up everywhere. We hold the power if we choose to exercise it while we lose that power if we passively comply.

Trucker convoy drives through mandates

As this Freedom Trucker fireman said, "I don't know what happened to our country. It's disgusting. There's nothing that's going to be taken from us here today that they're not going to take anyways – And people need to stand. With enough of us, they can't do this." See mark 1:58:10.

View: https://youtu.be/ZiIY5LpC890

If enough of us speak out NOW, collectively, we have the power to not only end the mandates, but to restore ALL freedoms in Canada, Australia, the UK, Europe and the United States, and we will win the day. We will never consent to authoritarian rule.

We will not leave a world of slavery to our children and grandchildren. We will protest every single day until the government realizes who truly is in charge. We believe in government of the people, by the people, and for the people. The cure for 1984 remains 1776.

Edward Dowd cautions those who continue to slumber, “If you are long these two stocks, you are long mandates, you are long government control, and you are long the selling of your freedoms.” Let us get everyone on board the freedom train. See mark 15:16.

Former Executive of BlackRock Edward Dowd7

With enough of us (awake), they can’t do this. Americans and Canadians are united in Freedom!

https://rumble.com/vvaw0n-urgent-message-to-canadians.html
 

marsh

On TB every waking moment
View: https://www.youtube.com/watch?v=70yn9vdW1iE
9:38 min

Can Vaccines Help with Long COVID?

Feb 25, 2022


MedCram - Medical Lectures Explained CLEARLY


Roger Seheult, MD of MedCram looks at the relationship between vaccines and long COVID. See all Dr. Seheult's videos at: https://www.medcram.com (This video was recorded on February 25, 2022) Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine. LINKS / REFERENCES: Vitamin D and Long COVID (MedCram) | https://youtu.be/NZ4rZaMMN7I Efficacy of COVID-19 vaccination on the symptoms of patients with long COVID: a target trial emulation using data from the ComPaRe e-cohort in France (Nature) | https://www.researchsquare.com/articl...
 

Heliobas Disciple

TB Fanatic
Another suggestion from Profit of Doom.

(fair use applies)


The Global Disinformation Campaign to Suppress the Evidence of Efficacy of Ivermectin
After a week of non-stop lectures, panels, speeches, and expert testimony, my new mission has now come into focus.
As one of the world’s leading experts on the clinical use of ivermectin in covid-19, I feel that it is my personal responsibility to try to create a historical record of the myriad actions taken against ivermectin by the global vaccine and pharmaceutical industry due to ivermectin’s long known and now proven role as the singlegreatest solution to the global pandemic.



All subsequent “Disinformation Campaign Against Ivermectin” posts should be understood in this vein. My previous post of my recent testimony in Senator Ron Johnson’s historic expert panel hearing detailed the incredible efficacy reported by the numerous health ministries around the world that deployed ivermectin in early treatment programs. Note that I did not even bother to detail the sixty-eight of seventy-seven controlled trials involving 86,000 patients from twenty-six countries (many of them prospective, double blind, randomized controlled trials) that collectively report massive reductions in infections, hospitalizations, and deaths, nor the dozen systematic reviews and meta-analyses (summary analyses of all the trials) that report the same. Nor did I present the analyses done after removing all the trials being attacked as low quality or “potentially fraudulent”—which actually found the signals of benefit increased.

I am tired of presenting the efficacy data. The “debate” of the efficacy of ivermectin has long ceased to be a “data argument,” despite the attempts to make it one by claiming the world over that it’s efficacy is “unproven” due to the supposed fact that these many dozens of trials are all low quality, small, and/or fraudulent. For sure, such assertions have successfully injected such doubt that the near entirety of academic medicine in nearly all the world’s countries have accepted it as scientific truth. These assertions can and should only be understood as a massive global propaganda and censorship campaign against the efficacy data. That is why I believe the only way forward is to expose each and every one of “their” disinformation tactics. If I am successful in doing this, it is my hope that this may begin to help end the decades-long war of the pharmaceutical industry against repurposed, generic medicines.

I feel the case of ivermectin may be a unique opportunity given that, in their pervasive war on numerous off-patent, effective therapies in dozens of disease models over decades, never has a single generic drug posed as large a threat to industry profit, nor have they ever committed such openly brazen and widespread criminalities using unprecedented levels of informational control. It is my belief and hope that their insane and relentless over-reach to protect profits in the global pandemic, similar to Napoleon’s foray into Russia, just may have opened an opportunity to so fully expose their deadly tactics that we can begin to counter them on a global scale.

Never has a single generic drug posed as large a threat to industry profit, nor have they ever committed such openly brazen and widespread criminalities using unprecedented levels of informational control.

Let us be clear, that all of these nefarious actions, which I will detail in numerous subsequent posts in this series, could only have been made possible by their massive and/or direct control of numerous major national and international public health agencies, mass media outlets, social media companies, high-impact medical journals, and captured researchers. Their ability to exert such fearsome power allowed them to suppress and/or distort the knowledge of the lifesaving efficacy against covid-19 of one of the worlds safest, most widely available, and inexpensive medicines. Never forget that these actions have resulted in millions of deaths. These are crimes against humanity.

The only way to stop future pharmaceutical industry crimes against humanity is to record, for posterity, the historically unprecedented scale of censorship and propaganda of information that they deployed. If I can help expose this playbook (with my little Substack—delusions of grandeur?), we have a shot at developing countering and/or neutralizing measures to prevent further massive deaths in this disease—as well as many other diseases. Note that the nefariousness of these actions can only be dwarfed by their scale, as they have impacted survival outcomes in almost the entirety of planet Earth’s citizens.

Although I will document these depraved actions, in most cases I will be unable to suggest or truly identify the ultimate or specific protagonists. You know: The actual individuals deploying these tactics, the ones making the ad buys and providing the “messaging,” paying the journalists and researchers for their media hit jobs, publishing the “negative” medical journal editorials and studies, partnering with the occasional U.S sociopath health agency leader, etc. Although I will be unable to identify them personally, employing logic, the only possible source of sufficient power to have exerted such widespread influence, would be the managers of the three multi-trillion dollar investment firms that have influential and/or controlling stakes in almost all corporations in almost all industries, and those three are: Black Rock, State Street, and Vanguard. Or it may have been the occasional pseudo-philanthropist-vaccine-obsessed-eugenicist-hundred-billionaire who, along with massive controlling donations to all the major international and national health agencies, also distributed hundreds of millions amongst almost every major media outlet in the world. That investigative exercise is not what I am skilled in, as I am just a lowly physician expert in ivermectin who has held a front row seat to now fourteen months of their deadly successful disinformation campaign against ivermectin. Instead, I simply plan to document every detail of every action that I have witnessed and/or have been personally involved in…and hope the investigative authorities can take care of the rest.

It’s time for the cops. It’s time for the prosecutors. And it’s time for the judges. And then it’s time for the prisons.
But first: The evidence.

Stay tuned.

P.S. I just want to say how much I appreciate all the subscribers to my substack, and especially the paid ones! Your support is so greatly appreciated. Thanks my friends.

A guest post by Pierre Kory, MD, MPA
Pulmonary and Critical Care Specialist, Teacher/Researcher. Co-Developer of effective, evidence/expertise-based COVID Treatment protocols with the medical professionals and science giants of the Front-Line COVID-19 Critical Care Alliance

Editor’s Note: Dr. Pierre Kory brought ivermectin’s remarkable efficacy against covid-19 to global attention with his December, 2020, Senate testimony, which received nearly nine million YouTube views before Google/YouTube censored it. As he continues to lead the Front Line COVID-19 Critical Care Alliance and treat covid patients in private practice, Kory is making a historical record of his witness of the government and media corruption that has kept repurposed drugs out of the hands of doctors and covid sufferers. This guest post is part one of the series.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


A National Vaccine Pass Has Quietly Rolled Out – And Red States Are Getting On Board
Suzanne Rowan Kelleher
Feb 24, 2022,10:40am EST


Even as the omicron variant loosens its grip on the world, destinations continue to require travelers to show proof of vaccination. And, increasingly, a paper CDC vaccination card is not cutting it.

While the United States government has not issued a federal digital vaccine pass, a national standard has nevertheless emerged. To date, 21 states, the District of Columbia and Puerto Rico offer accessibility to the SMART Health Card, a verifiable digital proof of vaccination developed through the Vaccination Credential Initiative (VCI), a global coalition of public and private stakeholders including Microsoft, Salesforce, Oracle, the Mayo Clinic and other health and tech heavyweights.

And very soon, at least four more states will be rolling out access to SMART Health Cards. “We've seen a notable uptick in states that have officially launched public portals where individuals can get verifiable vaccination credentials in the form of SMART Health Cards with a QR code,” says Dr. Brian Anderson, co-founder of the VCI and chief digital health physician at MITRE.

There is already an impressively widespread availability of SMART Health Cards in the U.S. More than 200 million Americans can now download, print or store their vaccination records as a QR code. When the QR code is pulled up, only the individual’s name, date of birth and vaccination information is visible. No other medical information or personal data is shared. This code is also digitally signed to ensure that the card was issued from a verified location and to prevent forgery.

SMART Health Cards Ease Travel

For individuals, the benefits of having access to personal digital vaccine record is three-fold. First, it’s a huge plus for travel in the U.S. and abroad.

Many indoor cultural attractions and performance venues in the U.S. require proof of vaccination. “We believe it gives people peace of mind when the folks around them are unlikely to be contagious,” says Gus Warren, CEO of Bindle, a health verification app that allows venues to verify the vaccination status of patrons.

Bindle’s growing list of clients spans more than 30 states, from blue strongholds like California and New York to red leaners like Texas, Florida, Arkansas, Missouri and Georgia. At the Kennedy Center in Washington, D.C., for example, there's a Bindle lane that offers fastpass-like efficiency in scanning QR codes from a number of vaccine verification platforms used around the world.

“The SMART Health Card is such an important development and the Vaccine Credential Initiative has been phenomenal in getting this out there,” says Warren, noting that while Bindle recognizes several interoperable standards, the SMART Health Card has emerged as the most important. “Absolutely, it has become the standard across the U.S. and North America.”

“And at an international level, we are continuing to see intense interest in a coordinated international approach,” says Anderson. “And that has not diminished at all. I think quite the opposite.”

To wit: Every Canadian province has now adopted SMART Health Card verification, as has Aruba, the Cayman Islands, Singapore and Japan. And in Africa, the SMART Health Card has rolled out in Kenya and Rwanda, just the first of 32 African countries in the “Smart Africa” alliance to adopt a digital-first approach to healthcare records.

The Case For Red States

The second argument for adopting a digital vaccine verification system is the one swaying red-state governors: Having digital access to personal health records empowers the individual.

More than a dozen states have launched their own SMART Health Card-based portals. At least seven others — including Arizona, Mississippi and West Virginia — have turned to a third-party, MyIRMobile, to issue SMART Health Cards. Minnesota has chosen Docket, another third-party option.

Most right-leaning states offering SMART Health Cards do it quietly, without any fanfare. But big red South Carolina expects to roll out a portal for SMART Health Cards by the end of March, reports Politico.

“This isn’t a passport,” South Carolina’s director of immunizations told Politico. “This is essentially a Covid card that people get at their convenience because it’s their record.”

Utah was one of the first red states to get on the SMART Health Card train. For former Utah Governor Mike Leavitt, a Republican who was the Secretary of Health and Human Services in the George W. Bush administration, the issue boils down to individual rights. “There's always a question about who owns the data and the rights to access that data,” Leavitt said at a recent global forum on SMART Health Cards. “But one thing is unchallengeable. And that is, I own a right to have my own data. And to have it in a form that I can present it conveniently for the kinds of things I want to do.”

“The idea of being able to have trustworthy copies of your own health records is not a red or blue state issue,” echoes Anderson. “ It is an individual empowerment of your own health data. What we're going to see over the next month is a growing number of red states recognizing and appreciating the importance of empowering their individual citizens in their states.”

This Won’t Be The Last Pandemic

Lastly, having a vaccine verification system in place prepares the U.S. for the next coronavirus variant as well as the inevitability of a future pandemic.

Today the main threat to our health and economy remains the omicron variant, says Anderson. “But it's going to be pi in a couple months, and it's going to be the same situation. Yes, we're going to get to an endemic phase of all of this, but that doesn't change the need to continue to protect the citizens of a nation from highly transmissible and communicable diseases.”

“Vaccination verification will be increasingly important at an international level,” Anderson says. “And so if we want to enable all of our citizens from every state to be able to participate in the safe travel across international boundaries and to participate in international commerce, it'd be important for our government officials from every state to enable this.”

Where Else To Get A SMART Health Card

Given the political landscape, Anderson recognizes that some states may never get on board. “We're not going to have all 50 states leveraging this approach,” he says. “But the vast majority of the vaccinated individuals in the US – over 200 million of them – already have the ability right now to go and get one of these credentials.”

That includes anyone vaccinated at any branch of Walmart, Sam’s Club, CVS, Duane Reade, Walgreens, Costco, Kroger, Rite-Aid or any of the dozens of other companies participating in the retail pharmacy program. To access an electronic version of your vaccination record, log into the online Covid portal of the brand where you got your shots.

And whether your state is red or blue, your healthcare provider is increasingly likely to offer a digital vaccination record. More than 100 major health systems and hospital groups across the country now offer SMART Health Cards to patients.

These include Kaiser Permanente, Tenet Health, Scripps Healthcare, Cerner and other healthcare heavy hitters. Big regional healthcare groups in the SMART consortium span the country, from Centra Health in Virginia to UCHealth in Colorado and from CoxHealth in Missouri to SoutheastHEALTH in Alabama and Georgia.
.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


New C.D.C. Guidelines Suggest 70 Percent of Americans Can Stop Wearing Masks
The agency issued a new set of recommendations intended to help communities live with the virus and get back to normal life.

By Apoorva Mandavilli
Feb. 25, 2022

The Centers for Disease Control and Prevention on Friday offered a new strategy to help communities across the country live with the coronavirus and get back to some version of normal life.

The new guidelines suggest that 70 percent of Americans can now stop wearing masks, and no longer need to social distance or avoid crowded indoor spaces.

The recommendations no longer rely only on the number of cases in a community to determine the need for restrictions such as mask wearing. Instead, they direct counties to consider three measures to assess risk of the virus: new Covid-related hospital admissions over the previous week and the percentage of hospital beds occupied by Covid patients, as well as new coronavirus cases per 100,000 people over the previous week.

Based on these three factors, counties can calculate whether the risk to their residents is low, medium or high, according to the agency, and only areas of high risk should require everyone to wear a mask. But unvaccinated people should wear masks even in low-risk areas, the agency said.

The agency had endorsed universal masking in schools since July, regardless of virus levels in the community, but the new guidelines recommend masking in schools only in counties at high risk.

The new guidelines are being released as the coronavirus is in retreat across the country. Case numbers have dropped to levels not seen before the surge of the Omicron variant, and hospitalizations have been plummeting. About 58,000 people are hospitalized with Covid nationwide, but those numbers have fallen by about 44 percent in the past two weeks.

Several experts said the new guidelines were appropriate for the country’s current situation. Although the number of cases nationwide is still high, “we’re well past the surge,” said Linsey Marr, an aerosol scientist at Virginia Tech. “We don’t need to be operating in emergency mode anymore.”

But many places have already shed pandemic restrictions. Most states have eased rules for mask-wearing, and some, like New Jersey, have announced plans to lift mandates even in schools. Others are poised to end indoor mask mandates in the coming weeks. An official recommendation from the C.D.C. may hold some sway in districts that have been more cautious.

Under the C.D.C.’s previous criteria, 95 percent of the counties in the United States were considered high risk. Using the new criteria, fewer than 30 percent of Americans are living in areas with a high level of risk, the agency said.

The new set of guidelines gives people a framework for adapting precautions as virus levels change, Dr. Rochelle Walensky, the C.D.C.’s director, told reporters on Friday.

“We want to give people a break from things like masking when our levels are low, and then have the ability to reach for them again should things get worse in the future,” she said. “We need to be prepared and we need to be ready for whatever comes next.”

Those who are particularly vulnerable because of their age, health status or occupation may choose to take extra precautions, regardless of the risk level in their community, she added.

The availability of high-quality masks such as N95 respirators allows individuals at high risk to continue to protect themselves even if others around them are not taking precautions, Dr. Marr said.

She added that it was good that the agency would continue to monitor cases because hospital rates can lag by two to three weeks. “By the time hospitals are overwhelmed, it’s too late,” she said.

But Dr. Walensky said C.D.C. scientists tested models with data from previous surges to confirm that the new method of calculating risk would have detected the surges early.

The Omicron surge made it clear that because so many Americans have some immunity to the virus through vaccinations or prior infection, counties may see high numbers of cases and yet comparatively few that involve serious illness. The new guidelines nod to that reality, and allow for a more sustainable approach to living with the virus, public health experts said.

“It just looked wrong that the whole country was a single shade of red,” said Jennifer Nuzzo, an epidemiologist at Johns Hopkins University’s Bloomberg School of Public Health.

Though a growing number of political leaders, public health experts and ordinary citizens now support the easing of restrictions, at least temporarily, others are still wary. They note that millions of people in the United States — including children under 5 — and billions around the world remain unvaccinated, making the emergence of a dangerous new variant not just possible but likely.

The C.D.C. and the Biden administration have declared victory prematurely before, including last spring when they told vaccinated Americans they could go mask-free and celebrate a “summer of freedom,” only to see the Delta variant send hospitalizations and deaths soaring again.

The White House has been working on a pandemic exit strategy that would help Americans live with the virus. But Dr. Walensky said just two weeks ago that it was not yet time to lift mask mandates. And some officials in the C.D.C. and the Department of Health and Human Services are nervous about the changing guidance, according to an administration official who spoke on condition of anonymity.

Some public health experts also balked at the easing of restrictions, noting that the country is recording roughly 1,900 Covid-related deaths every day, children under 5 still do not have vaccines available to them and significant numbers of Americans remain at high risk because of their age, health status or occupation.

The agency’s new guidelines do not address whether and for how long people who test positive for the virus should isolate themselves, noted Dr. Robby Sikka, who chairs the Covid-19 Sports and Society Working Group, an organization that oversees safety for professional sports teams.

A study published by the C.D.C. on Friday suggested that about half of those who tested positive remained contagious after five days — the length of isolation that the agency currently recommends. “If people isolate for five days, or even worse, we just let people go, it’s possible that we have the potential to see cases rise,” Dr. Sikka said.

Even people who do not become seriously ill may suffer long-term consequences from an infection, noted Zoë McLaren, a health policy expert at the University of Maryland, Baltimore County. “We are making pandemic policy under the assumption that the mass infection that occurred during the Omicron wave has few to no health consequences in the population, but there is growing evidence that Covid infection often has persistent health effects,” she said.

In an open letter to elected officials, a group of 400 experts in public health and education opposed the push to lift indoor mask mandates, saying it was “premature and threatens to place children, their school communities, and their families at greater risk for illness, disability, and death.”

“The challenge right now is that we need to consider, certainly, hospital capacity, but we also need to be considering vaccination uptake among children, among adults,” said Sonali Rajan, an expert in school health programs at Columbia University and one of the authors of the letter.

Ideally, the C.D.C. would continue to refine its models for assessing risk in communities, including incorporating signals from wastewater analysis and other approaches, said Joseph Allen, an expert on buildings quality at the Harvard T.H. Chan School of Public Health.

“One thing is clear, there is no bright line cutoff for any of these metrics,” Dr. Allen said. “I hope C.D.C. avoids that pitfall again.”
 

Heliobas Disciple

TB Fanatic
(fair use applies)

More evidence Covid was tinkered with in a lab? Now scientists find virus contains tiny chunk of DNA that matches sequence patented by Moderna THREE YEARS before pandemic began
  • Genetic match discovered in Covid's unique furin cleavage site on spike protein
  • Matched genetic sequence patented by Moderna for cancer research purposes
  • Researchers say one in 3trillion chance Covid developed the code naturally
By Connor Boyd Deputy Health Editor For Mailonline
Published: 12:48 EST, 23 February 2022 | Updated: 14:50 EST, 23 February 2022

Fresh suspicion that Covid may have been tinkered with in a lab emerged today after scientists found genetic material owned by Moderna in the virus's spike protein.

They identified a tiny snippet of code that is identical to part of a gene patented by the vaccine maker three years before the pandemic.

It was discovered in SARS-CoV-2's unique furin cleavage site, the part that makes it so good at infecting people and separates it from other coronaviruses.

The structure has been one of the focal points of debate about the virus's origin, with some scientists claiming it could not have been acquired naturally.

The international team of researchers suggest the virus may have mutated to have a furin cleavage site during experiments on human cells in a lab.

They claim there is a one-in-three-trillion chance Moderna's sequence randomly appeared through natural evolution.

But there is some debate about whether the match is as rare as the study claims, with other experts describing it as a 'quirky' coincidence rather than a 'smoking gun'.

SARS-CoV-2, which causes Covid, carries all the information needed for it to spread in around 30,000 letters of genetic code, known as RNA. The virus shares a sequence of 19 specific letters with a genetic section owned by Moderna. Twelve of the shared letters make up the structure of Covid's furin cleavage site, with the rest being a match with nucleotides on a nearby part of the genome's furin cleavage site, with the rest being a match with nucleotides on a nearby part of the genome

SARS-CoV-2, which causes Covid, carries all the information needed for it to spread in around 30,000 letters of genetic code, known as RNA. The virus shares a sequence of 19 specific letters with a genetic section owned by Moderna. Twelve of the shared letters make up the structure of Covid's furin cleavage site, with the rest being a match with nucleotides on a nearby part of the genome.

54562479-0-image-a-42_1645638343665.jpg

Moderna filed the patent in February 2016 as part of its cancer research division, records show. The patented sequence is part of a gene called MSH3 that is known to affect how damaged cells repair themselves in the body. It was approved on March 7 the following year

In the latest study, published in Frontiers in Virology, researchers compared Covid's makeup to millions of sequenced proteins on an online database.

The virus is made up of 30,000 letters of genetic code that carry the information it needs to spread, known as nucleotide

The US-based pharmaceutical firm filed the patent in February 2016 as part of its cancer research division, records show.

The patented sequence is part of a gene called MSH3 that is known to affect how damaged cells repair themselves in the body.

Scientists have highlighted this pathway as a potential target for new cancer treatments.

Twelve of the shared letters make up the structure of Covid's furin cleavage site, with the rest being a match with nucleotides on a nearby part of the genome.

Writing in the paper, led by Dr Balamurali Ambati, from the University of Oregon, the researchers said the matching code may have originally been introduced to the Covid genome through infected human cells expressing the MSH3 gene.

Professor Lawrence Young, a virologist at Warwick University, admitted the latest finding was interesting but claimed it was not significant enough to suggest lab manipulation.

He told MailOnline: 'We're talking about a very, very, very small piece made up of 19 nucleotides.

'So it doesn't mean very much to be frank, if you do these types of searches you can always find matches.

'Sometimes these things happen fortuitously, sometimes it's the result of convergent evolution (when organisms evolve independently to have similar traits to adapt to their environment).

'It's a quirky observation but I wouldn't call it a smoking gun because it's too small.

He added: 'It doesn't get us any further with the debate about whether Covid was engineered.'

Dr Simon Clarke, a microbiologist at Reading University, questioned whether the find was as rare as the study claims.

He told MailOnline: 'There can only be a certain number of [genetic combinations within] furin cleavage sites.

'They function like a lock and key in the cell, and the two only fit together in a limited number of combinations.

'So it's an interesting coincidence but this is surely entirely coincidental.'

MailOnline has approached Moderna for comment.

Circumstantial evidence has long raised questions about the origin of Covid and its link to the Wuhan Institute of Virology.

The facility was known to be conducting experiments on bat coronavirus strains similar to the one responsible for the pandemic.

China insisted early and often that the virus did not leak from the lab, claiming that crossover to humans must have occurred at a 'wet market' in Wuhan that sold live animals.

Perhaps driven by animosity for then-US President Donald Trump, who embraced the lab leak theory early on, mainstream media and academics in the West heaped scorn on the possibility, calling it an unhinged conspiracy theory.

But leaked emails showed that top scientists advising the UK and US Governments expressed concerns about the official narrative privately.

Sir Jeremy Farrar, an eminent British expert who publicly denounced the theory as a 'conspiracy', admitted in a private email in February 2020 that a 'likely explanation' was that the virus was man-made.

The then-UK Government adviser said at the time he was '70:30 or 60:40' in favour of an accidental release versus natural origin.

In the email, sent to American health chiefs Dr Anthony Fauci and Dr Francis Collins, Sir Jeremy said it was possible Covid had been evolved from a Sars-like virus in the lab.

He went on that this seemingly benign process may have 'accidentally created a virus primed for rapid transmission between humans'.

But the British scientist was shut down by his counterparts in the US who warned further debate about the origins of the virus could damage 'international harmony'.

In the latest twist, a study earlier this month found traces of Covid samples that contained genetical material from humans, hamsters and monkeys and may have predated the official pandemic timeline.


China's official pandemic timeline of the coronavirus pandemic and the evidence that undermines it

Official timeline


Dec 8, 2019 - Earliest date that China has acknowledged an infection

Dec 31 - China first reported 'pneumonia of unknown cause' to the World Health Organisation

Jan 1, 2020 - Wuhan seafood market closed for disinfection

Jan 7 - President Xi Jinping discusses coronavirus outbreak with his politburo

Jan 9 - China makes public the genome of the coronavirus

Jan 11 - China reported its first death

Jan 13 - First case outside China is confirmed

Jan 20 - China's National Health Commission confirms human-to-human transmission

Jan 23 - Wuhan locked down

Jan 31 - WHO declared 'outbreak of international concern' as China admitted having thousands of cases

Feb 23 - Italy reports cluster of cases in first major outbreak in the West

May 29 - China claims virus did not originate in wet markets but in Chinese bats before it jumped to humans via an 'intermediary animal'

July 31 - Chinese researcher admits some coronavirus experiments conducted in lower biosafety labs

Dec 16 - WHO announces it will travel to Wuhan to probe origins of virus in January

Jan 5, 2021 - China denies entry to WHO's investigatory team

Feb 9 - WHO dismisses theory virus leaked from lab - backs China's claim it was imported from frozen meat

Mar 28 - Former US national security officials says intel shows 'there was a direct order from Beijing to destroy all viral samples' at Wuhan lab


New evidence

2012: Six miners struck down with with a mysterious flu-like illness in Mojiang cave in Yunnan.

They were found to have been infected with the closest known relative to Covid, sharing 97% of its genes.

Samples RATG13 are sent to the Wuhan Institute of Virology to be studied.

Sep 2019- Blood samples are taken in a lung cancer screening trial in Italy which later test positive for coronavirus

Oct - Whistleblower Wei Jingsheng claims China deliberately spread Covid at The World Military Games in Wuhan in October, two months before the rest of the world knew about the virus

Oct - Xi Jinping's authoritarian regime tried desperately to shut down whistle-blowers like Mr Jingsheng. Any references made in social media about a new SARS virus or 'outbreak' were censored

Oct-Dec - Rise in 'flu and pneumonia' cases in northern Italy which could be linked to coronavirus

Nov - Whistleblower Mr Jingsheng claims he took his concerns about the military games to senior figures within the Trump administration but was ignored

Nov - Intelligence report passed to agencies in Washington claims three members of staff at the Wuhan Institute of Virology sought hospital treatment in November 2019 after experiencing symptoms consistent with Covid

Nov - Sewage samples taken in Florianópolis, Brazil, suggest virus was present

Nov 10 - Milanese woman has a skin biopsy, producing a sample which later shows signs of the virus

Nov 17 - Leaked documents suggest case detected in China on this date

Dec - Doctors in China, including Li Wenliang, report existance of new type of respiratory infection. But Chinese police arrested him and eight of his colleagues for questioning - instead of publicising reports and warning public

Dec 1 - Chinese researchers report an infection on this date in a peer-reviewed study, but it has not been acknowledged by Beijing

Dec 18 - Sewage samples taken in Milan and Turin suggest virus was circulating in the cities

Dec 26 - Samples analysed suggested a new type of SARS was circulating as early as December 26, but Wuhan was not locked down until January 22

Jan 2020 - Sewage samples from Barcelona suggest virus was in the city

Jan 3 - Covid-19 infections begin sweeping across other nations including the U.S. as the WHO labelled the outbreak a Public Health Emergency of International Concern

May - Scientists at a government lab in California concluded that Covid-19 may have escaped from a facility in Wuhan

July - WHO chief Tedros Adhanom Ghebreyesus said China failed share vital raw data during their investigation in Wuhan. China rebuffed those claims

June 2021: Leading US virus expert Dr Anthony Fauci was warned Covid may have been engineered in a lab, emails publicly released reveal.

August: The world's first Covid-19 patient may have been infected by a bat while working for a Wuhan lab in China, WHO chief Dr Peter Embarek said

August: A damning report by Republicans in the US claims coronavirus leaked from the Wuhan Institute of Virology, shortly after the facility tried to improve air safety and waste treatment systems

The report also cited 'ample evidence' that lab scientists were working to modify coronaviruses to infect humans and such manipulation could be hidden.

October: US intelligence review into origins of pandemic does not reach a judgement on whether the virus emerged via animal-to-human transmission or a lab leak.

Chinese officials branded the report 'political and false'.

January 2022: Leaked emails from top UK scientist Sir Jeremy Farrar showed he admitted in February 2020 that it was a 'likely explanation' that the virus could be man-made. But he went on to brand the theory a 'conspiracy'.

February: Sir Farrar is called to be interviewed under oath at the US Congress. Officials want him to explain why he shifted away from the lab leak theory.




WHAT IS THE FURIN CLEAVAGE SITE?

SARS-CoV-2, which causes Covid, carries all the information needed for it to spread in around 30,000 letters of genetic code, known as RNA.

But it is the only coronavirus of its type to carry 12 unique letters that allow it to be activated by a common enzyme called furin.

This in turn makes the virus better at invading neighbouring cells.

The so-called furin cleavage site is located on the virus' spike protein, the structure that binds to human cells in the first place.

Scientists sometimes add this element to lab viruses to make them more infectious, but in nature, pathogens can acquire it by swapping genetic code with other members of their family.

The furin has been the focal point of intrigue for many scientists studying the origins of the virus because no other known member of Covid's family - a group called Sarbecoviruses - have the site.


The CEO of Moderna was asked about this by Maria Bartiromo. This is his reply:

[no surprise this clip is not on youtube, so you'll have to click on the link. It's only a little over a minute long]

Moderna CEO Admits Covid could have been Created in Wuhan Using Moderna's Genetic Sequence Patent
1min 39sec


What he says is that his scientist is looking into the data to see if it's accurate. It could be that covid escaped from a lab, humans make mistakes. So maybe they worked on virus enhancement or gene modification in the lab and it got out, it's possible. Scientists are analysing to see if it's real or not. When Maria follows up that the report says it matched a genetic sequence patented by Moderna for cancer research he says that's one of the things the team is looking at carefully to see if it's real or not. They have to look at the data.

.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Pfizer is Funding Facebook’s Fact-Checking Partner.
Another conflict of interest emerges, as Big Tech takes Big Pharma cash to censor critics.
by Natalie Winters
February 25, 2022

Pharmaceutical giant Pfizer Inc. is sponsoring journalism training programs utilized by Facebook to train its “fact-checking” partners and censor stories and posts critical of COVID-19 vaccines.

The International Center For Journalists (ICFJ) – itself funded by the Open Society Foundations amongst others – is partnered with Meta, Facebook’s parent company, on its “Journalism Project” initiative. In turn, Facebook relies on the journalists funded and trained by ICFJ to “combat misinformation” on its platform through its controversial fact-checking operation.

Together, Facebook and the ICFJ have funded news outlets based in Africa, Latin America, and the Middle East with a focus on COVID-19 reporting.

Facebook’s fact-checking partner ICFJ, however, also receives financial backing from Pfizer, with its recently announced 2022 Arthur F. Burns Fellowship – named after a former Federal Reserve chairman – lists the pharmaceutical giant as one of the program’s sponsors.

“ICFJ’s longest-running program, the Arthur F. Burns Fellowship provides talented young U.S., German and Canadian journalists the opportunity to live and work in each other’s country,” explains a program summary. The program has produced dozens of alumni who “now work as foreign correspondents in 20 countries for well-known news outlets, such as The Washington Post, Reuters, CNN, ARD, Deutsche Welle and the Süddeutsche Zeitung,” according to the ICFJ.

Get On Gettr
Screen-Shot-2022-02-22-at-11.34.29-PM-800x438.png

ICFJ Program Sponsors.


The financial relationship with Pfizer dates back to at least 2008, as the center partnered with the pharmaceutical firm on a “training workshop on journalistic coverage of health issues” across Latin America.

“The objective of the workshop is to generate greater awareness about the importance of coverage of health issues in the region and to remember how the media can become leading actors when it comes to informing and educating the public about health issues. that directly affect your health and quality of life,” explains a summary.
EPISODE 76: Is This REALLY All Putin's Fault, And Why Is Google Funding This Weird Indian Fact Check Team?
The sole sponsor of the workshop, which also addressed reporting on “cardiovascular diseases,” was Pfizer.

The unearthed financial ties between Pfizer and Facebook’s fact-checking operation follow the pharmaceutical giant having additional conflicts of interest with news outlets including Reuters.

.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Rare Multisystem Inflammatory Syndrome Detected in Vaccinated Young: Lancet Study
By Naveen Athrappully
February 25, 2022

Some vaccinated youngsters in the 12–20 age group have reported a hyper-inflammatory condition where the body’s immune system goes into overdrive and shows symptoms of fever and systemic inflammation involving multiple organ systems, according to a study published Tuesday.

There were a total of 5,973 cases of Multisystem Inflammatory Syndrome in Children (MIS-C) reported to the MIS-C national surveillance system of the U.S. Centers for Disease Control and Prevention (CDC) between May 14, 2020, and Nov. 30, 2021.

MIS-C usually manifests two to six weeks after inoculation and is characterized by severe illness that requires hospitalization.

The authors of the peer-reviewed Lancet study looked into data between Dec. 14, 2020, and Aug. 31, 2021, and “identified 21 individuals with MIS-C after COVID-19 vaccination.”

Those 21 individuals were aged between 12 and 20 years old, with 13 individuals male and eight female. Eleven of them developed MIS-C after receiving the first dose of the vaccine, with the remaining 10 developing the illness after taking the second dose.

“All 21 were hospitalized: 12 (57 percent) were admitted to an intensive care unit and all were discharged home. 15 (71 percent) of 21 individuals had laboratory evidence of past or recent SARS-CoV-2 infection, and six (29 percent) did not,” the report said.

In total, over 21 million 12 to 20-year-old individuals had received at least one dose of a COVID-19 vaccine as of Aug. 31, 2021, putting the rate of MIS-C among this age group at one per million. The reporting rate among those without evidence of COVID-19 infection was only 0.3 per million vaccinated individuals.

These rates are lower than a previous study on the issue that had proposed an MIS-C reporting rate of 224 per million among individuals aged 11 to 15 and a rate of 164 per million among those aged between 16 and 20.

“The pathogenesis of MIS-C is hypothesized to involve a dysregulated immune response to SARS-CoV-2 infection, and host genetics might alter susceptibility to developing MIS-C,” the authors wrote.

Another study found that 98 percent of MIS-C hospitalizations were among unvaccinated pediatric patients. According to the researchers, MIS-C cases tend to peak after the peak in COVID cases.

Out of the 699 pediatric hospitalizations for COVID-19, 513 cases or 73 percent were found among unvaccinated individuals, claimed the study published at Epic Research on Jan. 28. “Of the 1,499 pediatric hospitalizations for MIS-C, 1,474 (98 percent) were for unvaccinated patients,” from the research report.

In its Jan. 14 Morbidity and Mortality Weekly Report (MMWR), the CDC proposes that two doses of Pfizer vaccine had an estimated effectiveness rate of 91 percent against MIS-C, thus suggesting its use among individuals between the ages of 12 and 18. However, MMWR is not a medical journal or peer-reviewed, but only CDC policy advocacy.

The National Institutes of Health (NIH) has proposed multiple treatment options for pediatric patients with MIS-C. This includes initial immunomodulatory therapy, intensification immunomodulatory therapy, antithrombotic treatment, antiviral therapy, and critical care management.
.
 

Heliobas Disciple

TB Fanatic
FROM CANADA:



(fair use applies)

Employee severance claims over vaccine mandates could become stronger as restrictions lift: lawyer
Michael Lee
Published Thursday, February 24, 2022 9:01AM EST | Last Updated Friday, February 25, 2022 11:24AM EST

With more provinces rolling back their pandemic restrictions, including vaccine mandates, the legal case to compensate employees dismissed because of vaccine policies could become stronger, one lawyer says.

Alex Lucifero, an Ottawa-based employment lawyer with Samfiru Tumarkin LLP, said when it comes to reinstating employees on unpaid leave, some may be recalled while others, particularly those who are non-unionized, don't have much chance of returning to work.

"The only recourse that those employees would have would be one of severance," he said.

As provinces continue to ease restrictions and loosen mandates, he says he believes the argument to owe employees severance will become stronger.

"What that means is that those employers took on a degree of risk and liability when they let these employees go," he said. "They should have expected that they would have owed these employees severance."

Samfiru Tumarkin reported receiving thousands of questions in recent months about vaccine mandates as many people were let go or placed on unpaid leave for not being vaccinated against COVID-19.

Lawyers who spoke to CTVNews.ca last month said wrongful dismissal claims, as they relate to vaccine mandates, would likely favour the employee given current legal precedent.

How those claims will be sought will depend on whether an employee is unionized or not. Where unionized employees would bring a grievance through their union, non-unionized employees would typically go to court.

While it is within an employer's right to let someone go, he said that is the case as long as an employee is properly compensated, which can depend on factors such age, years of service and position. An employee could potentially receive up to 24 months of severance, depending on their years of service.

But Lucifero said severance packages often fall short of what an employee is owed.

Although a number of mixed rulings have been rendered through labour arbitration, Lucifero said it's too early to tell how the situation will play out in court.

"I think the legal principles are strong in the sense that these employees will ultimately be successful in being owed severance, that is effectively what a wrongful dismissal claim is ultimately about," he said.

"It's simply about the correct amount of severance being paid to these employees. Those cases are working their way through the court system and it will likely be several months until a decision is actually reported."
.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Growing Number of Experts Call on US Government to Recognize Natural Immunity
CDC vaccination schedule should incorporate prior infection, experts say
By Zachary Stieber
Feb 23 2022

A growing number of experts are urging the U.S. government to formally recognize natural immunity, or the protection given by recovering from COVID-19.

More experts are arguing that the Centers for Disease Control and Prevention’s (CDC) recommended vaccination schedule should feature fewer doses—or none at all—for people who have contracted COVID-19 and survived.

“Natural infection should count as two doses,” Dr. Paul Offit, professor of pediatrics at the Children’s Hospital of Philadelphia, and an adviser to the Food and Drug Administration on vaccines, told The Epoch Times.

Offit and two former FDA officials stated in a recent op-ed that “requiring people who have been infected to get three shots is overkill at best—a waste of valuable doses—and an unnecessary risk at worst (given that vaccines have side effects, albeit rare ones).”

Under current CDC guidance, all Americans 12 and older are advised to get three doses of the Moderna or Pfizer COVID-19 vaccines. The CDC defines fully vaccinated as people who get two shots of the Moderna or Pfizer COVID-19 vaccines, or the single-shot Johnson & Johnson jab.

The CDC’s guidance isn’t binding but is cited by companies and jurisdictions when imposing vaccine mandates. Many mandates force workers or residents to get fully vaccinated; others require a booster on top of the primary series because of waning protection. Few have exemptions for natural immunity.

Eric Topol, founder and director of the Scripps Research Translational Institute, wrote in a separate op-ed that the increasing number of studies showing how strong and long-lasting natural immunity is should prompt the CDC to redefine fully vaccinated in two ways: People who have gotten a primary series and not been infected should need a third dose, while those with prior infection should only need one shot.

Recent research on the matter includes a study funded by Johnson & Johnson and the U.S. government that found that previous infection alone provided 90 percent protection against moderate to severe COVID-19—the vaccine only provided 56 percent protection—and a paper backed by the CDC that found natural immunity was more protective than vaccination against the Delta variant of SARS-CoV-2.

Some experts, such as Offit, push for what’s known as hybrid immunity. They point to papers that suggest that people who have been infected and go on to get a single vaccine dose are better protected than those with prior infection who remain unvaccinated, including a Cleveland Clinic study published earlier in February.

Dr. David Boulware, a professor of medicine at the University of Minnesota, agrees.

Boulware said he worries that not everybody who contracts COVID-19 will generate an immune response. He helped with a study published in 2021 that had participants self-collect serologic samples. The findings indicate that people with more COVID-19 symptoms were more likely to show evidence of prior infection.

“For persons with prior documented COVID-19, they should receive at least one follow-up vaccine at three to six months after initial infection. For those with prior infection, two sequential vaccines in rapid sequence of 0, 21, or 28 days do virtually nothing immunologically, other than generate side effects. At present (based on current rules), I would recommend all those with prior infection to have a vaccine at three months after initial infection and then again after six months from initial infection,” Boulware told The Epoch Times in an email.

Top U.S. health officials such as CDC Director Dr. Rochelle Walensky have acknowledged that natural immunity occurs but have repeatedly urged people to get vaccinated, even if they recover from COVID-19, with a full vaccination schedule.

Offit says he was among four people who were asked to share their views on natural immunity in 2021 with Walensky and other officials, including Dr. Anthony Fauci, the longtime head of the National Institute of Allergy and Infectious Diseases (NIAID) and the chief medical adviser to President Joe Biden. The virtual meeting, which took place after Surgeon General Vivek Murthy was confirmed by the Senate and before Dr. Francis Collins stepped down as head of the National Institutes of Health (NIH), didn’t lead to a shift in government guidance.

“I think it’s because the opinions were sort of generally diverse, so there wasn’t a clear, unified message that came out of that,” Offit told The Epoch Times.

One possible issue is how people could prove they’ve been infected and recovered, with suggestions including serologic tests.

The CDC, the NIH, NIAID, Murthy, Walensky, Fauci, and Collins didn’t respond to requests for comment. The Epoch Times has filed Freedom of Information Act requests for details on the meeting.

Other experts say the protection people with natural immunity enjoy is so strong that they may not or definitely don’t need any vaccine doses.

Dr. Robert Malone, who helped create the messenger RNA technology that the Pfizer and Moderna vaccines are built on, pointed to research that suggests that people with natural immunity have a greater risk of suffering adverse events after getting vaccinated as well as a collection of studies on protection from natural immunity.

“Over 140 papers demonstrate that—superiority of natural immunity,” Malone told The Epoch Times. “And furthermore, if you jab somebody after they have natural immunity, their risk of adverse events goes up.”

One recent study from Italian researchers found that people who recovered from COVID-19 had a low risk of reinfection and a very low risk of severe or deadly COVID-19. They said the risk-benefit of vaccine doses for the population should be “carefully evaluated.”

“From the point of view of the individual who recovered from a previous infection, vaccination will provide a very limited benefit, as his/her risk of a severe or lethal disease is extremely low, especially if she/he is young,” Dr. Lamberto Manzoli, one of the authors, told The Epoch Times in an email.

On the other hand, vaccinating the naturally immune “may still provide some benefit, because approximately 1 percent of these subjects may have a reinfection and therefore transmit the disease,” he said. “Clearly, their impact on the overall pandemic is difficult to quantify, and it is likely to be very scarce, but if we want to take a very conservative approach, vaccination may still provide some benefit. Importantly, we have to use the word ‘may’ because, as I mentioned in the manuscript, an in-depth evaluation of the risk-benefit should be made for these subjects.”
.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Can Algae-Based Nasal Spray Prevent COVID-19?
By University of Pittsburgh
February 25, 2022

A nasal spray derived from algae and a plant in the tobacco family could offer a preventive measure for COVID-19, according to a new study.

Researchers are making a molecule called Q-griffithsin using an anti-viral protein found in the New Zealand red algae Griffithsia and Nicotiana benthamiana, a plant in the same family as tobacco plants. The former has shown it can bind to other coronaviruses’ surfaces, making it unable to infect healthy cells.

“The nice thing about Q-griffithsin is that it has a number of activities against other viruses and pathogens,” says Lisa Rohan, a professor in the pharmaceutical sciences department at the University of Pittsburgh School of Pharmacy, and one of the lead researchers on the collaboration.

“It’s been shown to be effective against Ebola, herpes, and hepatitis, as well as a broad spectrum of coronaviruses, including SARS and MERS.”

The team envisions a nasal spray for people at higher risk of contracting COVID-19, such as health care and emergency medical service workers, and people with weak immune systems.

While the spray wouldn’t replace any successful COVID-19 vaccines developed in the future, it could provide an effective level of defense against the coronavirus for immune-compromised individuals who can’t take vaccines, Rohan says.

“The vaccine will also be specific for this particular coronavirus, while the nasal spray can be used for a broad spectrum of diseases,” she says. “Also, given Q-griffithsin’s broad spectrum activity against coronaviruses, it has potential to thwart future infections.”

Researchers formulated the drug into a nasal spray to fight COVID-19 because the virus typically enters through the nose and mouth, which the spray can target before it infects the lungs and creates more serious complications.

Though researchers use tobacco plants to manufacture the proteins, people who use the spray won’t receive the harmful effects associated with ingesting or inhaling tobacco. Researchers typically regard plants as a safe production platform for biopharmaceuticals.

“The end result is all protein, so there’s nothing from the plant itself. We purify the plant, so there’s no harmful components left. It’s like when people use bacteria to make antibiotics,” says Kenneth Palmer, chair in pharmaceutical plant-based research at the University of Louisville.

Rohan’s lab originally developed formulations for Q-griffithsin as a potential preventive for human immunodeficiency virus (HIV). Palmer’s lab has also tested Q-griffithsin on a number of viruses.

The HIV preventive project received funding from the National Institutes of Health’s Division of Allergies and Infectious Diseases. However, after seeing the fast spread of COVID-19, Rohan and Palmer looked back at previous data indicating the effectiveness of Q-griffithsin against other forms of coronavirus.

“This is a product that already has a nice safety profile and has an application that has allowed it move forward in the clinic. We believe this is a product we can rapidly advance in a realistic way,” Rohan says. “With adequate funding, we’re hoping to move the product into the clinic.”

This article was originally published by University of Pittsburgh. Republished via Futurity.org under Creative Commons License 4.0.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Target Ends Masking Requirement for Workers, Customers
By Zachary Stieber
February 25, 2022

Customers and workers at most Target stores no longer have to wear masks.

The Minnesota-based retailer updated its policies on Feb. 21, saying masks won’t be required as long as local regulations don’t force stores to require them.

“The health and safety of our guests and team members have been Target’s top priority throughout the pandemic. As COVID-19 cases continue to decline across the country, Target will not require our U.S. team members or guests to wear masks, as local regulations allow,” Target said in a statement.

“We’ll follow all state and local COVID-19 safety regulations and encourage our team members and guests to consult the latest public health guidance, get vaccinated and make decisions to keep themselves and their families safe,” it added.

Target has 1,926 stores in the United States and employs approximately 350,000 workers.

It wasn’t clear how many stores will still require masks due to local restrictions.

The retailer in August 2021 imposed the masking requirements in all counties designated high risk for COVID-19 transmission by the Centers for Disease Control and Prevention (CDC). Some 82 percent of the country falls under that designation as of Feb. 25.

Target will keep other safety and cleaning measures in place, including disinfecting, a company spokesperson told The Epoch Times in an email.

“We’ll also continue to provide our team with resources and benefits they need, including free medical-grade masks, COVID-19 tests, paid leave for team members with positive COVID-19 cases, and paid time and free Lyft rides to reduce barriers for team members to get their vaccines. Finally, we’ll continue to monitor trends in COVID-19 cases, public health data and guidance from public health experts moving forward. As the external environment changes, we will reevaluate and evolve our COVID-19 response for our team, operations and guests as needed,” the spokesperson said.

Other large retailers have eased mask mandates in recent weeks as COVID-19 cases and hospitalizations plunge across the country.

Walmart and Sam’s Club workers were told in mid-February that they can stop wearing masks, provided they’re fully vaccinated and work in a store that is not located in a jurisdiction that requires masking. Workers who are employed in “clinical care settings,” such as pharmacies, are also still forced to don face coverings.

Vaccinated workers can continue to wear masks, Walmart said in a memo. “We support and respect an individual’s choice to continue wearing one,” company officials said. Customers are not required to wear masks.

Amazon also said recently that masks would no longer be required for fully vaccinated employees, provided local regulations don’t force masking indoors.

Fully vaccinated means a person has received two doses of the Moderna or Pfizer COVID-19 vaccine, or the single-shot Johnson & Johnson jab.

The masking guidance update came due to a “sharp decline in COVID-19 cases across the country over the past weeks along with increasing vaccination rates across the country,” an Amazon spokesperson told The Epoch Times, adding, “This is a positive sign we can return to the path to normal operations.”

A slew of the states and counties that still forced people to mask in various settings have also totally withdrawn or partially withdrawn their masking mandates, citing the drop in COVID-19 metrics.
.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

CDC Finally Ditches Indoor Masking Guidance For Majority Of US (Including Schools)
by Tyler Durden
Friday, Feb 25, 2022 - 04:40 PM

Just as Dr. Rochelle Walensky had hinted a little more than a week ago, the CDC on Friday finally eased its masking guidance for schools and other public areas, liberating millions of Americans from strict requirements that mandated mask wearing in most - if not all - public places.

According to the updated guidance, more than 70% of the US now falls under the "low" or "medium" COVID community level, meaning masks aren't recommended for use by the general public.

In areas with a "high" level of spread (currently about 30% of the US population) masks would still be recommended in public indoor settings, and under the "medium" level, people at higher risk are encouraged to speak with their doctor about wearing a mask. But under the "medium" and "low" areas, the CDC doesn't recommend masking.

Readers can find a breakdown of the new guidelines below:


Source: CDC

And here's a breakdown of how those levels correspond to different parts of the US.


Source: CDC

Under the new guidelines, universal masking in schools - a subject of particularly intense debate - is now only recommended in areas with a "high" level of community spread.

“This updated approach focuses on directing our prevention efforts toward protecting people at high risk for severe ailments and preventing hospitals and healthcare systems from being overwhelmed,” Dr. Rochelle Walensky, the CDC’s director, told reporters on a call.
Walensky said the CDC “came up with indicators, including new hospital admissions and hospital beds utilized” and combined “them with case incidents to really create a packet of metrics to be able to understand what’s happening at the local level.”
According to the CDC, the new guidelines were designed with hospital capacity in mind, unlike the previous metrics, which were focused on overall case numbers, a reflection of a new phase of dealing with the pandemic as the wave of omicron infections has declined.

The 7-day average for new cases in the US was 74,750 on Thursday, down sharply from levels that topped 1 million per day in January. Hospitalizations are also falling, and death counts have begun declining, too. One reason for the sharp drop in cases is that Americans are now more frequently testing themselves.



The new federal guidance comes after governors across the country have ditched their masking guidance, while many liberal cities have done the same (even notorious holdout LA County has just begun to "relax" its masking policy).

Dr. Walensky said people can still wear masks if they want, but that the US is in "a stronger place as a nation."

"We are in a stronger place as a nation when it comes to protecting our communities and ourselves against severe disease because of our efforts – like vaccination, improvements in testing, high quality masks, and improved ventilation – and because of living with this virus for two years."
"The overall risk of severe disease is now generally lower. Still, the virus will continue to circulate in our communities, and we must prevent COVID-19 from overwhelming our hospitals and healthcare systems."[​

Meanwhile, Jeffrey Zients, a White House official, did not deny the White House had been in touch with the CDC on revising its masking recommendations but said the CDC was "in the lead here on both the substance and the timing of masking guidance," per the Epoch Times.

More than 35 states had already ditched their masking requirements, according to the National Academy for State Health Policy. Some, largely Republican-led states, never allowed local officials or school districts to impose masking requirements in the first place.

The question many want to get an answer to now is... when will the airplane mask mandate end?
.
 

Heliobas Disciple

TB Fanatic
View: https://www.youtube.com/watch?v=BQSXRzBSoks

TWiV 870: COVID-19 clinical update #103 with Dr. Daniel Griffin
44min 18 sec
Feb 26, 2022
Vincent Racaniello

In COVID-19 clinical update #102, Daniel Griffin covers immunocompromised people, hospitalization of children, vaccine usage update, Omicron and cross-reactive neutralizing antibodies, reinfection prevents disease in hamsters, repeated infections with endemic coronaviruses, global burden of antimicrobial resistance, ivermectin not protective in hamsters, and Omicron evades therapeutic monoclonals. Show notes at https://www.microbe.tv/twiv/twiv-870/
.
 

Heliobas Disciple

TB Fanatic
View: https://www.youtube.com/watch?v=J1pWGOigwe8

Can I catch omicron twice
6 min
Feb 25, 2022
Dr. John Campbell

Yes you can but the chance is only 1 in 38,279 infections Occurrence and significance of Omicron BA.1 infection followed by BA.2 reinfection Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark https://bit.ly/3s5QYWt Omicron carries numerous mutations in key regions and is associated with increased transmissibility and immune escape. Omicron BA.1 and BA.2 Whether BA.2 specifically can escape the natural immunity acquired shortly after a BA.1 infection N = 1,8 million infections November 22, 2021, until February 11, 2022 Individuals with two positive samples, more than 20 and less than 60 days apart From a total of 187 reinfection cases, we identified 47 instances of BA.2 reinfections shortly after a BA.1 infection, (So from 1,800,000 million, 47 did and 1,799.853 didn’t) mostly in young unvaccinated individuals with mild disease not resulting in hospitalization or death. In conclusion, we provide evidence that Omicron BA.2 reinfections do occur shortly after BA.1 infections but are rare.
 

Heliobas Disciple

TB Fanatic
View: https://www.youtube.com/watch?v=sDzbdNV8L20

Is new omicron more severe
8min 59sec
Feb 25, 2022
Dr. John Campbell

From Danish data, no, but more younger people are admitted to hospital Risk assessment of Omicron BA.2 https://en.ssi.dk/-/media/arkiv/subsi... The Omicron SARS-CoV-2 variant has quickly become dominant in many countries, significantly higher growth potential than the Delta variant Omicron variant is more transmissible than the Delta variant Secondary Attack Rate BA.1 29% BA.2 39% and it has shown reduced sensitivity to neutralizing antibodies. Vaccine induced protection against infection is also clearly reduced for the Omicron compared to the Delta variant. Transmissibility is lower in fully vaccinated individuals and even lower in booster vaccinated individuals, compared to unvaccinated Preliminary analyses a 36%-80% risk reduction in hospitalization for the Omicron compared with the Delta with most studies reporting a risk reduction between 45%-68%. Omicron Lineages B.1.1.529, BA.1, BA.2 and BA.3. BA.1 accounts for 97% of omicron worldwide Denmark Week 52, 2021, 20% Week 3, 2022, 66% an increase in the proportion of BA.2 and a decrease in the proportion of BA.1 BA.2 is probably beginning to take over in India, Philippines, European countries Qatar, BA.2 seems to be dominant Increased growth potential Higher transmissibility and/or increased ability to evade the immune system compared to BA.1. Current knowledge about severity no difference in hospital admission risk was detected for BA.1 and BA.2 (n = 932 patients) BA,1 median age of hospital admission, 51 BA,2 median age of hospital admission, 40
 

Heliobas Disciple

TB Fanatic
(fair use applies) EMPHASIS COPIED OVER, not by me

Pfizer for Kids: Dodgy Data and Conflicts of Interest
By Sonia Elijah
February 25, 2022

The Joint Committee on Vaccination and Immunisation (JCVI), an independent group of experts who advise the UK’s government health departments on immunisations published a report on 16 February stating, ‘JCVI advises a non-urgent offer at two 10mcg doses of the Pfizer-BioNTech Covid-19 vaccine to children aged 5 to 11 years of age who are not in a clinical risk group.

I recently interviewed Dr Tony Hinton, a retired NHS surgeon of 35 years, regarding the JCVI’s recent statement, which I posted on my substack. Dr Hinton found it to be full of contradictions and the CDC data that the JCVI relied upon to be skewed, in comparison to data recorded in a Hong Kong study, yielding significantly different vaccine-related myocarditis rates in children.

The following day, a breaking news story by The New York Times, came to my attention, what it revealed helps explain why the CDC data appears to be so irregular. The article exposed the fact that the CDC (Centre for Disease Control in the US) had been withholding vast amounts of Covid data from the public. It stated: ‘Two full years into the pandemic, the agency leading the country’s response to the public health emergency has published only a tiny fraction of the data it has collected.’

The article went on to quote, Samuel Scarpino, managing director of pathogen surveillance at the Rockefeller Foundation’s Pandemic Prevention Institute, who said, “The C.D.C. is a political organization as much as it is a public health organization.”

His bombshell statement helps make a strong case that the US Covid policy (including the vaccine programme) has been governed by politics all along, rather than the science.

Furthermore, the JCVI and the MHRA have relied unquestioningly on Pfizer’s clinical trial data to authorise and recommend the experimental Pfizer-BioNTech vaccine comprising of the novel lipid nanoparticle formulation containing nucleoside-modified mRNA.

The same clinical trial data that’s been cast into serious doubt by recent whistle-blowers, like Brook Jackson, the regional director of several of the clinical trial sites used in Pfizer’s pivotal Phase III trial, which the BMJ covered, last November.

The Pfizer and BioNTech funded evaluation report

What’s highly concerning is that the study published in the NEJM (The New England Journal of Medicine) which the JCVI included in their recent report, when evaluating vaccine safety of the Pfizer-BioNTech (BNT162b2) vaccine in children aged 5-11- was entirely funded by Pfizer and BioNtech, with the authors of the study directly working for either company. It’s also disturbing, how nobody at the JCVI would have sounded the alarm bells of ‘conflict of interest’ but instead chose to remain silent and rely on that far from independent study.

The Pfizer and BioNTech funded report states that ‘Covid-19 vaccines are urgently needed in children younger than 12 years of age’ and of course concludes that the Pfizer-BioNTech (BNT162b2) vaccine is ‘safe, immunogenic, and efficacious in children 5 to 11 years of age.’ The report alarmingly states, ‘Without effective Covid-19 vaccines for this age group, children could potentially become ongoing reservoirs of infection and sources of newly emerging variants.’

In my opinion, for children to be described by Pfizer and BioNTech as ‘ongoing reservoirs of infection’ is offensive and epitomises the way they have been treated for the past two years-including being labelled as ‘super-spreaders.’ There have been several highly credible reports citing evidence, which state otherwise.

The major contradictions of the JCVI report

There were many irregularities of JCVI’s ‘non-urgent offer’ which stood out to Dr Hinton. Firstly, in all his years in medicine, Dr Hinton has never come across the JCVI use that type of language when recommending an immunization. From the beginning of the interview, he said that the JCVI are not recommending the vaccine for this age group – it says it will be an “open non urgent offer to parents.” The term itself exposes the fact that there is no urgent need to offer the vaccination for this age group- so why offer it anyway?

One of the reasons they give for their ‘non urgent offer’ is to prevent a future wave of infection’ whilst making note of the fact that the vaccination of this group ‘is not expected to have an impact on the current wave of Omicron.’

For over a year now, evidence has shown that the COVID-19 vaccines and their boosters, do not prevent people from contracting the virus or prevent transmission. Indeed, Israel rolled out the fourth dose of the Pfizer Vaccine in early January, and since then has experienced skyrocketing Covid-19 cases. So, how would vaccinating young healthy children prevent a future wave of infection? It cannot and it’s unusual that the JCVI would make this claim.

The report importantly states that young children have ‘asymptomatic or mild disease’following infection with SARS-CoV-2 and that ‘children aged 5 to 11 are at the very lowest risk from COVID-19’ which completely renders hollow their non-urgent offer.

The case for natural immunity

Another anomaly that stood out in the report that Dr Hinton highlighted was the JCVI’s admission that ‘over 85% of all children’ would have already contracted SARS-CoV-2, leading to acquired natural immunity. Prima facie, this seems like welcome news, given the relentless dismissal of one of the fundamental principles of immunology by global government health bodies and public health officials- natural immunity. The report goes on to rightfully assume that ‘Natural immunity arising from prior infection will contribute towards protection against future infection.’ The JCVI appear to directly contradict themselves as their ‘non-urgent offer’ of the Pfizer-BioNTech vaccine for young healthy children, appears to be based on the threat of a future infection.

The data

In the interview, I mentioned that the JCVI had relied on CDC data (which we now know only a tiny fraction has been released to the public). I read out an extract from their report, ‘In the United States (linked to CDC Covid-19 Vaccine Task Force report) less than 2 cases of vaccine-related myocarditis have been reported per million doses.’

Dr Hinton believed that rate to be much higher. He said “even if it was based on 2 cases of myocarditis per million, given there are 5.6 million 5–11-year-olds in the UK that would give rise to 11 cases of myocarditis, with a possibility 50% death rate over 5 years. Plus, you’re looking at 3 cases of possibly not going to ICU versus 11 cases of vaccine-related myocarditis.”

Dr Hinton spoke about a Hong Kong study that was done which gives a much more accurate picture of vaccine-related myocarditis cases in children.

“From the first dose there were 55 recorded cases per million, from the second dose it jumped to 370 cases per million, so altogether they had 425 cases per million injections. So, for us to vaccinate 5.6 million children in the UK, that would lead to 2380 cases- far higher than what the JCVI say.”

In the interview, I mentioned a recent study published on January 25, 2022, in JAMA(Journal of the American Medical Association) which showed the risk of myocarditis following mRNA COVID-19 vaccination (Pfizer and Moderna vaccines) ‘was increased across multiple age and sex strata and was highest after the second vaccination dose in adolescent males and young men. This risk should be considered in the context of the benefits of Covid-19 vaccination.’

Since the study in JAMA was published well before the JCVI released their statement, the experts in the group should have been aware of this peer-reviewed study and included it when considering vaccine safety rather than simply relying on a non-peer-reviewed, Pfizer-funded Covid-19 vaccine evaluation report.

Based on the very recent damning evidence against the CDC and the alarming conclusion of the new study in JAMA, the JCVI need to immediately withdraw their statement.

On February 11th, 90 medical professionals forming the group, Children’s Covid Advisory Group (CCVAG) wrote a letter to the government ‘to pause the child Covid vaccine rollout pending results of an investigation into serious safety signals.’
Their letter was ignored by the government and the JCVI. In response, 500 British medical professionals co-signed the original letter and a small group of representatives hand delivered it to the JCVI and the Chief Medical Officer, on February 24th.
.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Repurposing FDA-Approved Drugs To Combat All COVID-19 Variants – Including Delta and Omicron
By Penn State University
February 25, 2022

Several FDA-approved drugs — including for type 2 diabetes, hepatitis C and HIV — significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists at Penn State. Specifically, the team found that these drugs inhibit certain viral enzymes, called proteases, that are essential for SARS-CoV-2 replication in infected human cells.

“The SARS-CoV-2 vaccines target the spike protein, but this protein is under strong selection pressure and, as we have seen with Omicron, can undergo significant mutations,” said Joyce Jose, assistant professor of biochemistry and molecular biology, Penn State. “There remains an urgent need for SARS-CoV-2 therapeutic agents that target parts of the virus other than the spike protein that are not as likely to evolve.”

Previous research has demonstrated that two SARS-CoV-2 enzymes — proteases including Mpro and PLpro — are promising targets for antiviral drug development. Pfizer’s COVID-19 therapy Paxlovid, for example, targets Mpro. According to Jose, these enzymes are relatively stable; therefore, they are unlikely to develop drug-resistant mutations rapidly.

Katsuhiko Murakami, professor of biochemistry and molecular biology, Penn State, noted that these virus proteases, because of their capabilities to cleave, or cut, proteins, are essential for SARS-CoV-2 replication in infected cells.

“SARS-CoV-2 produces long proteins, called polyproteins, from its RNA genome that must be cleaved into individual proteins by these proteases in an ordered fashion leading to the formation of functional virus enzymes and proteins to start virus replication once it enters a cell,” Murakami explained. “If you inhibit one of these proteases, further spread of SARS-CoV-2 in the infected person could be stopped.”

The findings were published today (February 25, 2022) in the journal Communications Biology.

The team designed an assay to rapidly identify inhibitors of the Mpro and PLpro proteases in live human cells.

“Although other assays are available, we designed our novel assay so it could be conducted in live cells, which enabled us to simultaneously measure the toxicity of the inhibitors to human cells,” said Jose.

The researchers used their assay to test a library of 64 compounds — including inhibitors of HIV and hepatitis C proteases; cysteine proteases, which occur in certain protozoan parasites; and dipeptidyl peptidase, a human enzyme involved in type 2 diabetes — for their ability to inhibit Mpro or PLpro. From the 64 compounds, the team identified eleven that affected Mpro activity and five that affected PLpro activity based on a cut-off of 50% reduction in protease activity with 90% cell viability.

Anoop Narayanan, associate research professor of biochemistry and molecular biology, monitored the activity of the compounds using live confocal microscopy.

“We designed the experiment so that if the compound was affecting the proteases, you would see fluorescence in certain areas of the cell,” said Narayanan.

Next, the team evaluated the antiviral activity of the 16 PLpro and Mpro inhibitors against SARS-CoV-2 viruses in live human cells in a BSL-3 facility, the Eva J. Pell ABSL-3 Laboratory for Advanced Biological Research at Penn State, and discovered that eight of them had dose-dependent antiviral activities against SARS-CoV-2. Specifically, they found that Sitagliptin and Daclatasvir inhibit PLpro, and MG-101, Lycorine HCl and Nelfinavir mesylate inhibit Mpro. Of these, the team found that MG-101 also hindered the virus’s ability to infect cells by inhibiting protease processing of the spike protein.

“We found that when the cells were pretreated with the selected inhibitors, only MG-101 affected the virus’s entry into cells,” said Narayanan.

In addition, the researchers found that treating cells with a combination of Mpro and PLpro inhibitors had an additive antiviral effect, providing even greater inhibition of SARS-CoV-2 replication.

“In cell culture, we showed that if you combine Mpro and PLpro inhibitors, you have a stronger effect on the virus without increasing toxicity,” said Jose. “This combination inhibition is highly potent.”

To investigate the mechanism by which MG-101 inhibits the activity of Mpro protease, the scientists, including Manju Narwal, postdoctoral scholar in biochemistry and molecular biology, used X-ray crystallography to obtain a high-resolution structure of MG-101 in complex with Mpro.

“We were able to see how MG-101 was interacting with the active site of Mpro,” said Narwal. “This inhibitor mimics the polyprotein and binds in a similar manner to the protease, thereby blocking the protease from binding to and cutting the polyprotein, which is an essential step in the virus’s replication.”

Murakami added, “By understanding how the MG-101 compound binds to the active site, we can design new compounds that may be even more effective.”

Indeed, the team is in the process of designing new compounds based on the structures they determined by X-ray crystallography. They also plan to test the combination drugs that they already demonstrated to be effective in vitro in mice.

Although the scientists studied the Delta variant of SARS-CoV-2, they said the drugs will likely be effective against Omicron and future variants because they target parts of the virus that are unlikely to mutate significantly.

“The development of broad-spectrum antiviral drugs against a wide range of coronaviruses is the ultimate treatment strategy for circulating and emerging coronavirus infections,” said Jose. “Our research shows that repurposing certain FDA-approved drugs that demonstrate effectiveness at inhibiting the activities of Mpro and PLpro may be a useful strategy in the fight against SARS-CoV-2.”

Reference: “Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay” by Anoop Narayanan, Manju Narwal, Sydney A. Majowicz, Carmine Varricchio, Shay A. Toner, Carlo Ballatore, Andrea Brancale, Katsuhiko S. Murakami and Joyce Jose, 25 February 2022, Communications Biology.
DOI: 10.1038/s42003-022-03090-9

Other authors on the paper include Sydney A. Majowicz, graduate student, and Shay A. Toner, undergraduate student, Penn State; Carmine Varricchio, postdoctoral research associate, and Andrea Brancale, professor of medicinal chemistry, Cardiff University; and Carlo Ballatore, professor of medicinal chemistry, University of California, San Diego.

The National Institutes of Health, Welsh Government Office for Science and Huck Institutes of the Life Sciences at Penn State (COVID-19 Seed Grant for Jose Laboratory) supported this research.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Fourth dose of COVID vaccine may not be needed for most people… yet
by Bob Yirka,
Science X Network, Medical Xpress
February 25, 2022

A team of researchers working at Israel's Sheba Medical Center has found evidence that suggests a fourth COVID vaccination or second booster shot may not be necessary for most people because it does not add significant protection. In their paper posted on the medRxiv preprint server, the team describes comparing people who were given a second booster shot with people who were not.

As the pandemic has progressed, medical researchers have worked hard to develop vaccines to keep people from getting sick and therapies to help those afflicted. As a result, vaccines were developed by several companies that proved to prevent serious infections. Booster shots of the same vaccines were then found to provide protection again months later as immune response to the vaccines waned. Since that time, many people have wondered if they will need another booster shot as protection from the first booster starts to wane. In this new effort, the researchers sought to find the answer.

It was not a coincidence that the researchers were working in Israel—it is one of the few countries that has not waited to find out if a fourth shot is needed. Officials there have begun making second boosters available to those who want them. To determine the efficacy of second booster shots, the researchers recruited 1,000 healthcare workers who were fully vaccinated and who had received a booster shot. Two-hundred seventy-four received a second booster; the rest served as a control group. The researchers then measured antibody levels for all of the subjects.

They found that while the second booster did increase protection slightly, it was not by enough to justify its use—at least at this time. They also found that the second booster did not activate T cells. They suggest their results should not frighten people, however; they believe that most people are still adequately protected from their first three shots. Still, they do suggest that older people and those at risk for other reasons get a second booster if they can. Though such people were not included in the study, the researchers assume that any increase in protection for people more at risk is reason to get the shot.

Explore further COVID boosters keep older Americans out of hospitals: CDC
 

Heliobas Disciple

TB Fanatic
(fair use applies)

A potential antiviral for SARS and SARS-like coronaviruses
by Iqbal Pittalwala, University of California - Riverside
February 25, 2022

Both SARS-CoV-1, the virus that caused the 2003 outbreak of Severe Acute Respiratory Syndrome (SARS), and SARS-CoV-2, which causes COVID-19, originate from a group of betacoronaviruses known as "subgroup 2b." Coronaviruses from this subgroup have been highlighted as having significant potential to cross from animal hosts to humans with deleterious consequences, COVID-19 being the most recent one.

A coronavirus enzyme called papain-like protease, or PLpro, is one of two proteases that are required for the initial replication steps of the virus as well as silencing host immune responses, making this enzyme a sought-after drug target.

Scott Pegan, a professor of biomedical sciences in the School of Medicine at the University of California, Riverside, has led a team that investigated the PLpro from a subgroup 2b bat coronavirus, BtSCoV-Rfl.2004, to determine if identifiable trends in enzymatic activity exist within all subgroup 2b PLpros.

In a paper published in ACS Infectious Diseases, the team lays out the similarities in biochemical function among PLpros from SARS-CoV-2, SARS-CoV-1, and those of other SARS-like viruses already circulating among bats and other species. The work has revealed that unlike other types of coronaviruses, these subgroup 2b SARS and SARS-like coronaviruses seek to selectively target a specific form of ubiquitin—a small protein that exists in all eukaryotic cells—linked to key host immune pathways. Additionally, these PLpros have evolved to selectively target a ubiquitin-like protein known as ISG15 only from a subset of species.

With this information in hand, researchers can further zero in on how SARS and SARS-like viruses go undetected by the host immune system during the early stages of infection and which hosts specific coronaviruses have frequented.

"The pandemic has highlighted the urgent need to develop effective coronavirus therapeutics that can prevent current and future coronavirus subgroup 2b health threats," Pegan said. "Our paper highlights that PLpro is not just a valid drug target for the current threat of COVID-19, but for other coronaviruses from that group that could cross from animals to humans in the future. Our work has potential to develop a therapy effective against SARS-CoV-2 and other coronaviruses lurking around the corner."

Pegan explained that the conserved nature of PLpros among subgroup 2b coronaviruses presents an opportunity to develop inhibitors that can be used to thwart viral threats.

"Our goal is to open the door to future therapeutic design considerations for targeting PLpro as a strategy for pan-coronavirus subgroup 2b therapeutics," Pegan said.

Pegan and his colleagues used the PLpro of BtSCoV-Rfl.2004 as a tool alongside PLpros of SARS-CoV-1 and SARS-CoV-2 to push the development boundaries of two small molecule scaffolds shown by Pegan to have antiviral properties against SARS-CoV-1 and SARS-CoV-2. This led to the design of 30 next generation drug-like subgroup 2b PLpro inhibitors that
provide new directions for pan-coronavirus subgroup 2b antiviral developments of PLpro inhibitors.

In the paper, the researchers demonstrate that these types of compounds can be pan inhibitors of PLpro and highlight their safety profiles at a cellular level.

"In particular, we push forward the development of a set of compounds from which a practical therapeutic may come," Pegan said.

Pegan was joined in the research by several colleagues at the University of Georgia. Of these, David Crich led the compound synthesis team and served as co-designer of the compounds with Pegan; Ralph Tripp led the antiviral testing group; and Brian Cummings, now at Wayne State University, led the toxicology efforts.

The research paper is titled "Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses."

Explore further Promising path found for COVID-19 therapeutics
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Dr. Raszek: Pfizer Docs Show Spike Protein Enters Cell Nucleus
By Michelle Edwards
February 25, 2022

On Wednesday, a Canadian doctor presented evidence—straight from an Australian study on Pfizer’s COVID-19 “vaccine”—corroborating the idea that the spike protein in COVID-19 “vaccines” enters the cell nuclei. According to Dr. Mikolaj Raszek, this is the first evidence he’s seen to back up the discovery last year that the SARS-CoV-2 full-length spike protein potentially enters human cell nuclei and interferes with the mechanics of fixing broken and damaged DNA. If this is true, in theory, then the spike protein “could be a mutagen because it prevents the fixing of our DNA.”

Scientific evidence from Pfizer, presented to the Australian government confirming the possible entry of the spike protein into the cell nuclei. Spike protein in nucleus "NEWS" - COVID-19 vaccines update 32
— Merogenomics (@merogenomics) February 23, 2022
View: https://www.youtube.com/watch?v=4Unt03UBhbU
12min 18sec
Spike protein inside nucleus enhancing DNA damage? - COVID-19 mRNA vaccines update 18
Nov 12, 2021

With months spent examining COVID-19 vaccines, last November, Dr. Raszek, founder and managing director of Merogenomics, Inc., discussed (see video above) how the spike protein, post-vaccination, can circulate in the blood for months on end in the exosomes. Therefore, he states it could potentially circulate to any part of our body, including entering any cell and damaging the DNA. At the time, Raszek spoke of the first glimpse of the possibility, as indicated by a Swedish study, that the spike protein enters the cell nuclei. Now, he’s analyzed additional data from a Pfizer study released by Australian authorities tasked with approving medications. The study offers further evidence that the spike proteins do indeed enter the cell nuclei.

Australian Study Illustrates Transfection Frequency of Vaccine Spike Protein

RASZEK

Screenshot / Nonclinical Evaluation of BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY); Fig. 2-18, FACS analysis of transfection frequency and cell viability; pg. 34

Raszek explains that pg. 34 of the Jan. 2021 Australian Government’s “Nonclinical Evaluation Report” of “BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY),” section 2.3. Expression of Antigens refers to the spike protein itself that is being produced “from the genetic material introduced via the vaccine.” He noted that HEK293T cells, which are human embryonic kidney cells, are very standard cells to use in scientific studies.

In Fig. 2-18, he pointed out that the graph on the left-hand side (Transfection frequency) indicates how effectively the different vaccine constructs enter the cells, called transfection. Explaining the diagram, Raszek notes that when measuring the transfection of just the RNA itself (singled out from the rest of the ingredients in the Pfizer vaccine), as indicated by the black bar, the RNA alone was successfully able to enter the cells.

Next, when examining the gray bar (which represents all the ingredients in the vaccine, including the RNA), Raszek remarks the transfection frequency is even greater. Specifically, in this case, the RNA is encapsulated within a fat molecule called a lipid molecule. Notably, very thin layers of lipid molecules make up the cell membrane. Raszek explains, “Vaccine products themselves are inserted into their own independent little balls of fat, and this allows vaccines to be able to fuse directly with the cell membrane as they encounter the cells. You can see from this graph that such construct of the genetic material inside the vaccine lipid construct gets inside (transfects) the cells even easier than just the RNA alone.”

Image Reveals Vaccine Spike Protein Merging With Cell Nucleus

ER-Golgi.jpg

Screenshot / Nonclinical Evaluation of BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY); Figure 2-19. Immunofluorescence staining of transfected cells; pg. 35

Moving on, data on pg. 35 of the 58-page report reveals shockingly clear potential evidence that the vaccine spike protein enters the cell nucleus. Raszek points to Fig. 2-19—specifically the top row—stating it is important because “that’s where all these signals are being merged together.” Reiterating this is the second time he has seen any evidence showing the spike protein might be found inside nuclei, he explains further:

Going column by column across the top row, the first image in blue is a stain used to stain nuclei in cells (where genetic materials live—the brain of the cell).
The second column shows antibodies tagged with a fluorescent tag, allowing the antibodies to “give off a signal,” in this case, it is used to indicate proteins found inside the endoplasmic reticulum.
The third column shows the same technique but uses green to pick up the spike proteins. In this image, you can see the green indicates the spike protein is present in much of the cell.
The last image, which is the most important, merges all of the signals together. Again, the blue indicates where the nuclei is present with the cell, the red represents the endoplasmic reticulum, and the green represents spike protein.
But here, we see the additional color of yellow. Yellow is the overlapping signal between the endoplasmic reticulum (red) and the green spike protein. When the red and green signals overlap, they create the yellow signal. Here you can see that the vast majority of the endoplasmic reticulum is flashing yellow, meaning spike protein is being produced actively inside the cell.”

Dr. Raszek’s entire video, “Spike protein in nucleus “NEWS”—COVID-19 vaccines update 32,” is available below.

View: https://www.youtube.com/watch?v=WmeWdc6-mwg

Spike protein in nucleus "NEWS" - COVID-19 vaccines update 32
32 min 18 sec
Feb 23, 2022
 

Heliobas Disciple

TB Fanatic
Profit of Doom asked me to post this.

(fair use applies)

Evidence for Community Cloth Face Masking to Limit the Spread of SARS‐CoV‑2: A Critical Review
Of sixteen quantitative meta‐analyses, eight were equivocal or critical as to whether evidence supports a public recommendation of masks, and the remaining eight supported a public mask intervention on limited evidence primarily on the basis of the precautionary principle.
November 8, 2021 Working Paper No. 64
By Ian T. Liu, Vinay Prasad, and Jonathan J. Darrow

The use of cloth facemasks in community settings has become an accepted public policy response to decrease disease transmission during the COVID-19 pandemic. Yet evidence of facemask efficacy is based primarily on observational studies that are subject to confounding and on mechanistic studies that rely on surrogate endpoints (such as droplet dispersion) as proxies for disease transmission. The available clinical evidence of facemask efficacy is of low quality and the best available clinical evidence has mostly failed to show efficacy, with fourteen of sixteen identified randomized controlled trials comparing face masks to no mask controls failing to find statistically significant benefit in the intent‐to‐treat populations. Of sixteen quantitative meta‐analyses, eight were equivocal or critical as to whether evidence supports a public recommendation of masks, and the remaining eight supported a public mask intervention on limited evidence primarily on the basis of the precautionary principle. Although weak evidence should not preclude precautionary actions in the face of unprecedented events such as the COVID-19 pandemic, ethical principles require that the strength of the evidence and best estimates of amount of benefit be truthfully communicated to the public.


Working Paper - 64 - Cover

Download PDF
 

Heliobas Disciple

TB Fanatic
(fair use applies)

New Zealand High Court: Vaccine Mandate Not ‘Demonstrably Justified,’ Breach of Rights
Police and defence force staff challenge upheld
By Katabella Roberts
February 25, 2022

The New Zealand High Court has upheld a challenge to a vaccine mandate for Police and Defence Force staff, stating that it was not a “demonstrably justified” breach of the Bill of Rights.

Justice Francis Cooke was asked by a group of Police and Defence Force personnel to judicially review the vaccine mandate enacted under the COVID-19 Public Health Response Act in December.

The mandate required all Defence Force personnel and all Police constables, recruits, and authorized officers to receive two doses of the vaccine by March 1.

But on Jan. 6, three unvaccinated staff who did not wish to receive the shots sought a judicial review of the mandate. They were supported by affidavits from 37 of their colleagues in the same position.

The group claims that two rights of the New Zealand Bill of Rights Act 1990 had been limited by the mandate: the right to refuse a medical treatment and the right to manifest religious beliefs.

Part of the group’s religious objections to the mandate were concerns over the fact that “the Pfizer vaccine had at some point been tested on cells that had been derived from a human foetus.”

According to UCLA Health, COVID-19 vaccines do not contain aborted fetal cells but Johnson & Johnson did use fetal cell lines when developing and producing their vaccine, and Pfizer and Moderna used them to test their vaccines to ensure they work.

The group claimed that “requiring vaccination by such a vaccine was in conflict with the religious beliefs of some of the affected persons.”

Cooke, in a judgment (pdf) released on Friday in New Zealand, did not accept some of the applicants’ arguments but agreed that the mandate “is not a reasonable limit on rights that can be demonstrably justified” and set the order aside.
“I conclude that the Order does not involve a reasonable limit on the applicants’ rights that can be demonstrably justified in a free and democratic society and that it is unlawful,” Cooke said.

“The order limits the right to be free to refuse medical treatment recognised by the New Zealand Bill of Rights Act (including because of its limitation on people’s right to remain employed), and it limits the right to manifest religious beliefs for those who decline to be vaccinated because the vaccine has been tested on cells derived from a human foetus which is contrary to their religious beliefs,” Cooke said.

However, he pointed out the court’s decision did not affect any other vaccine mandates or any internal vaccination policies of the police or Defence Force.

“In essence, the order mandating vaccinations for police and NZDF staff was imposed to ensure the continuity of the public services, and to promote public confidence in those services, rather than to stop the spread of COVID-19. Indeed health advice provided to the government was that further mandates were not required to restrict the spread of COVID-19. I am not satisfied that continuity of these services is materially advanced by the order,” he said.

Cooke also concluded that the mandate affected only a small number of personnel: just 164 unvaccinated personnel in a police workforce of nearly 15,700. For the New Zealand Defence workforce, the mandate affected 115 of its 15,480 staff.

“Moreover there is no evidence that this number is any different from the number that would have remained unvaccinated and employed had the matter simply been dealt with by the pre-existing internal vaccine policies applied by police and NZDF. Neither is there any hard evidence that this number of personnel materially effects the continuity of NZDF and police services,” the judge wrote.

The judge also said it was apparent, based on evidence, that the Omicron variant of COVID-19 was highly transmissible and could affect a large number of New Zealanders including police or Defence temporarily but that the termination of jobs arising from the mandate was permanent.

“Vaccination has a significant beneficial effect in limiting serious illness, hospitalization, and death, including with the Omicron variant. But it was less effective in reducing infection and transmission of Omicron than had been the case with other variants of COVID-19,” the judge wrote.

However, Cooke stressed that his decision to set aside the order was not for “the purposes of limiting the spread of COVID-19” but for “the continuity of service of police and Defence.”

“But the order made in the present case is nevertheless unlawful and is set aside,” he wrote.

The applicants were awarded costs.

Associate Professor Helen Petousis-Harris, a vaccinologist at the University of Auckland told Stuff NZ that she was disappointed with the decision and that it legally and morally undermines the mandates.

“It’s really disappointing. These are temporary mandates. They are for the benefit of our whole community. Communities have always depended on our people cooperating and working together – right through time since we camped outside the caves. It’s an essential component of a successful society,” Petousis-Harris said.

“This isn’t working together. Right in the middle of a pandemic, it’s not in the spirit of trying to keep us all safe.”
Spokespersons for both Police and NZDF told The New Zealand Herald that terminations of staff who do not get vaccinated will be suspended while the decision is considered by the government.

The Epoch Times has contacted New Zealand Police and NZDF for comment.
 
Top